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The hematopoietic stem cells (HSCs) have been unquestionably important to therapies that 
involve blood and immune system replacement. However, the in-vitro culture and the expansion 
of HSCs inhibit their application. This work aims to develop a composite biodegradable 3D 
scaffold that would simulate key aspects of the in-vivo microenvironment (niche) in which 
expansion of the hematopoietic stem cells takes place in human bone marrow. Hydroxyapatite 
(HA) has been chosen as a scaffold material because of its biocompatibility and the ability to 
create an osteogenic scaffold and thereby simulate trabecular bone that is known to be important 
to the HSC niche in bone marrow. It is hypothesized that the use of a Ca-rich HA scaffold will 
create a three dimensional, protective environment for HSCs and further promote their in-vitro 
expansion by releasing Ca ions into the culture medium. .  
The first part of this study examined the processing of Ca-rich HA and the release of calcium 
ions into saline over time. The Ca-rich phase was introduced into the HA by an infiltration 
process and has been shown to release calcium into the culture medium over 42 days. The 
second part of this study examined the effect of the scaffold material on the fate of human 
umbilical vein endothelial cells (HUVECS), a well-known endothelial progenitor model.  The 
results showed, for the first time, that at least some HUVEC cells have hematopoietic potential 
and that the scaffold promoted differentiation down the hematopoietic cell lineage. This is 
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thought to be due to hemangioblast character in the HUVEC cells which is also shared by HSCs. 
Finally the effects of the scaffold on the in-vitro co-culture of an osteoblast cell line and primary 
human bone marrow derived HSCs was studied.  The infiltrated scaffolds were shown to 
stimulate the HSC population to differentiate down the hematopoietic lineage and also showed 
greater potential to differentiate down the HSC lineage in consequent CFU assays. 
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1.0  INTRODUCTION 
Tissue engineering is one of the most important approaches to tissue replacement and 
organ repair including bone repair1,2, eye transplantation3 and heart transplantation4.  This thesis 
is focused on materials engineering for bone marrow cell transplantation and Hematopoietic stem 
cell transplantation (HSCT). The latter is the transplantation of multipotent hematopoietic stem 
cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood. HSCT was 
first developed in the 1950s and has been the leading therapy for leukemia5, but it is also used in 
therapies for cancers of the blood, bone marrow and multiple myeloma. Since the first successful 
bone marrow transplantation was performed in 19686 , more and more patients have undergone 
this therapy and the total number of bone marrow transplant procedures reached 25,000 by the 
end of the 19887. In 2008 alone, 51,536 hematopoietic stem cell transplantations were reported 
to have occurred in 72 countries in a globalize survey conducted by the Worldwide Network for 
Blood and Marrow Transplantation8.  
However, bone marrow transplantation still exposes patients to significant life 
threatening risks. One important risk factor in this therapy is graft-versus-host disease following 
an allogeneic HSCT, because the white blood cells in the graft may target and attack cells in the 
host’s body. This risk persists even when there is more than 25 to 30 percentage of the same 
human leukocyte antigens (HLA) shared between the between the donor and the recipient.  
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Although this level is considered a perfect match there is still a chance of graft-versus-host 
disease9. 
Autologous HSCT is an alternative that would avoid such patient risk but unfortunately, 
the low availability of the patients own hematopoietic stem cells (HSCs) for re-implantation can 
inhibit this option. In autologous HSCT, it is necessary to collect the stem cells from the patient, 
treat them to separate the healthy hematopoietic stem cells and re-culture the stem cells in vitro 
to expand their number. During the consequent treatment to kill the cancer cells or because of 
infection factors, the patients remaining population of health hematopoietic stem cells decrease 
sharply. At present it is difficult to obtain an appropriate number of healthy stem cells after the 
patients undergoes a painful partial or complete bone marrow ablation10. This proposal, aims to 
provide a new material system that will increase the population of hematopoietic stem cells 
resulting from the vitro culture for subsequent repopulation of the bone marrow and thereby 
reduce the risk of HSC transplantation failure.  
Hematopoietic stem cells mostly exist in the bone marrow, which is the main 
hematopoiesis soft tissue and lies at the interior of long bones. When HSCs are harvested as bone 
marrow and cultured in-vitro environment, there will be other cells from the bone marrow tissue 
in the HSC microenvironments.  For example, osteoblast cells play an essential role in 
controlling the fate of HSCs in the endosteal microenvironment because they could localize 
human hematopoietic progenitor cells in the bone marrow. The endosteal microenvironment 
exists in the bone marrow at the inner bone surface while the central part of the trabecular zone 
contains the vascular microenvironment11 which is occupied by vasculature and capillaries by 
which the HSCs enter the blood stream.  
 3 
Therefore, the core aim of this work is to develop a composite biodegradable 3D scaffold 
that would simulate key aspects of the in-vivo microenvironment in which expansion of the 
hematopoietic stem cells takes place in the human body.  
In tissue engineering, hydroxyapatite (HA) has been widely used as artificial bone and 
bone substrate since it has a similar chemical formula as the main mineral component of human 
bone. It has excellent bioactivity, biocompatibility and osteoconduction12 that are the desired 
biological properties for bone grafts. With the development of the 3D cell culturing for tissue 
engineering, there has been more interest in culturing cells on porous hydroxyapatite scaffolds 
with suitable pores diameters and morphology. Indeed, studies13,14,15,16 have reported success on 
hydroxyapatite as the scaffold for the bone marrow cell niche, which refers to a specific 
anatomic location which regulates bone marrow cell participation in tissue generation, 
maintenance and repair17. In those studies, bone marrow cells were cultured in an in-vivo animal 
model. 
Among 3D cell culture studies, several reports have been published concerning the effect 
of calcium concentration on the hematopoietic stem cell proliferation and the differentiation in 
cell niche. Scadden reported that high ionic calcium concentrations that exist near active 
osteoclasts might influence stem-cell function17. At the site of active bone remodeling, ionic 
concentrations have been observed that dramatically exceed serum levels and vary with 
osteoclast activity. Shinya Nakamura et al18 also reported that the calcium ions will affect the 
osteogenic differentiation, in which pre-osteoblasts would differentiate to osteoblasts. 
In general, tissue engineering scaffolds must contain interconnected pores with a mean 
gate size between neighboring pores of 100 µm or greater, and open porosity of >50% to permit 
tissue ingrowth and function in porous scaffolds19.  The hydroxyapatite would be formed into 
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tiles which are high porous and meets the requirement of the tissue function scaffold. According 
to the HA ceramic manufacturing process, small connecting pores between the ceramic particles 
would disappear during full sintering while the large pores on macro-scale should not be 
effected. Such structural changes should allow another phase, such as Ca-rich phase, to be 
introduced into HA scaffolds without affecting the macro-pore structure  
In this study it was hypothesized that hydroxyapatite scaffolds containing soluble phases 
with relatively high calcium content could be used to effect hematopoietic stem cell expansion 
during in-vitro culture. In such case, over a period of 4 weeks, the steady release of calcium from 
an hydroxyapatite scaffold could promote the stem cell population expansion, or stimulate the 
HSCs differentiate down to the hematopoietic linage towards blood cells and cells for the 
immune system.. 
In a final application the in-vitro culturing materials developed in this study would be 
used to expand the population of HSCs harvested from a patient prior to bone marrow ablation 
after which the expanded population would be re-transplanted into the same patient. Also, the 
scaffolds might guide the HSCs differentiation into useful cell types, such as blood cells to 
augment the blood supply for rare blood types or lymphocytes, for cell therapies involving the 
immune system. 
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2.0  BACKGROUND 
2.1 REGENERATIVE MEDICINE 
Regenerative medicine involves replacing or regenerating cells, tissues or organs in the human 
body, in order to restore or establish normal function20. It includes cell therapy, gene therapy, 
tissue engineering and other methods, and it has enormous potential to treat and cure diseases21. 
2.1.1 Cell therapy 
As one of the main application of regenerative medicine, cell therapy is defined as the 
administration of cells to the body to the benefit of the recipient22. In cell therapy, cellular 
materials are injected into the patient’s body to cure cell level tissue damage. Cell therapy has 
two branches, one is the use of human cells transplanted from a human donor to a patient and has 
been used with some success in clinical application, the other, and rather more dangerous 
alternative is the use of animal cells to treat human illness, which needs much more research 
before moving to clinical application23. 
 Stem cells, which have genomic plasticity with unlimited ability for self-renewal, are 
highly desirable for cell therapy and have successfully been used in some clinic applications. 
One of these applications is hematopoietic stem cell transplantation, which helps patients to 
rebuild their blood and immune systems. In this transplantation, hematopoietic stem cells (HSCs) 
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are used by themselves or as part of a sample of bone marrow cells, which also include 
endothelial cells, osteoblast cells and other cell types. The field of cell therapy continues to 
advance towards new therapies for treating human disease 24. Notable examples include cell 
therapies for Lysosomal Storage Diseases, Parkinson's disease, Huntington's disease and brain 
tumors25. However stem cell science still needs more understanding of the behavior of implanted 
cells.  Nevertheless it is clear that cell therapies will contribute to growth of regenerative 
medicine and increase the demand for in-vitro expansion of stem cell supplies derived from 
human donors.   
2.1.2 Tissue engineering 
The field of tissue engineering is driven by the need to provide functional equivalents of native 
tissues that can be used for implantation. Modern society desires life-time enhancement, and so 
the need for tissue repair continues to grow. However, the field of tissue engineering is 
responding to it relatively slowly because of the issues which include: biological complexity, 
regulatory issues, and the high cost of new cell-based devices. At the same time, engineered 
tissues are finding new roles as models for fundamental research on disease, testing of drugs, and 
many other applications. In all cases, the requirements are to provide the cells with the 
appropriate cues, to control the conditions in the cell microenvironment, and to monitor cellular 
responses on multiple hierarchical levels. In order to develop a whole organism tissue, there are 
coordinated sequences that need to be followed including: cell renewal, differentiation, and 
assembly, within an ever-changing environment characterized by spatial and temporal gradients 
of multiple factors26.  
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In the general context of technologies for culturing cells and stem cells in particular, the 
environments for guiding stem cell function will be discussed, with a particular focus on two key 
components— biomaterial scaffolds and bioreactors. For both components, the interplay between 
molecular and physical regulatory factors will be considered while highlighting some of the 
important findings pertinent to the design of cell scaffold–bioreactor systems for applications in 
tissue engineering and biological and medical research13. 
2.1.3 Bioreactor 
Bioreactors are generally defined as devices in which biological processes (such as cell 
expansion, differentiation, or tissue formation on 3D scaffolds) occur under tightly controlled 
environmental conditions such as exchange of oxygen, nutrients, and metabolites, and 
application of molecular and physical regulatory factors26. Tissue-engineering bioreactors are 
designed to precisely regulate the cellular microenvironment needed to support cell viability, 3D 
organization and provide spatial and temporal control of cell signaling. These requirements 
translate into a set of practical design objectives: (i) rapid and controllable expansion of cells; (ii) 
enhanced cell seeding of 3D scaffolds (at a desired cell density, high yield, high kinetic rate, and 
spatial uniformity); (iii) efficient local exchange of oxygen, nutrients, and metabolites; and (iv) 
provision of physiological stimuli.13  
Bioreactor can be separated into two basic categories, stir tank and fixed bed. The stir 
tank consists of a vessel in which cells float freely in cell culture medium, and fresh culture 
medium can be continuously added while culture liquid is removed to keep the culture volume 
constant. A typical stirred-tank is shown in Figure 2.1. The culture medium contains components 
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such as nutrients, growth factors to support the culture of cells and antimicrobials27. The stir tank 
could provide a physiological steady-state and is ideal for non-adherent cells. 
 
Figure 2.1 Stirred-tank bioreactor uses baffles and an agitator for optimal mixing, and recycles biomass28. 
Carriers made from biocompatible polymers and ceramics can be used for culturing cells 
that usually grow on a surface29. The cells can attach to the carriers which are then suspended in 
the stirred tank reactor. 
The other type of bioreactor is the perfusion reactor, such as packed bed reactors29,30, 
fibrous bed bioreactor31 and the hollow fiber membrane reactors32 such as that shown in Figure 
2.2. In this type of reactor, cells are immobilized in a fixed chamber or core in the bioreactor and 
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the culture medium is perfused through the container. The architecture of the core is used to 
control the perfusion of culture medium and gases.  
 
Figure 2.2 Fixed bed reactor model with hollow fiber membranes33 
In all bioreactors, it is found that mechanical cues are important for both in-vivo and in-
vitro culture, including musculoskeletal and cardiovascular tissues34, such as osteoblasts and 
endothelial cells35,36. Mechanical forces could regulate cell fate, cell morphology cell physiology 
and the organization of the extracellular matrix, signaling, and biomechanics of the cellular 
microenvironment25.  During in- vitro culture, it is an important to create or provide similar 
mechanical conditions to those that govern in-vivo tissue development25. Perfusion bioreactor 
can control medium flow and shear forces as physiological stimuli and the effects have been 
reported on application to tissue engineering and cell culturing37,38.  For example, Sikavitsas et 
al39reported that there were more osteogenic genes expressed in osteoblasts under the shear 
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stresses were associated with medium flow. Other groups also reported a similar effect of flow 
on genes40and enhanced mineralization under mechanical forces41. 
2.1.4 Biomaterial scaffold 
In tissue engineering, the biomaterials used in implantations, known as the scaffold, can be made 
in a variety of shapes using different fabrication techniques42. During service, the scaffolds 
should meet the requirements of architecture and properties needed to provide a short term 
support for cell growth and new tissue formation. 
The ideal scaffold should43: (i) have a biocompatible (non-toxic) surface that promotes 
cell adhesion and proliferation;(ii) after in-vitro tissue culture, exhibit mechanical properties that 
are comparable to those of the tissue to be replaced; (iii) have a porous three dimensional (3-D) 
architecture to allow vascularization and diffusion of nutrients between the cells seeded within 
the matrix; (iv) degrade at a rate that matches the production of new tissue, into nontoxic 
products that can be easily resorbed or excreted by the body; (v) be capable of being processed 
economically into anatomically relevant shapes and dimensions, and sterilized for clinical use. In 
modern tissue engineering, biomaterial scaffold should also play an important role in biomimetic 
simulation of the microenvironment, or niche, in which stem cells reside in the body. It should 
allow the cells to attain their natural morphology and also mimic the chemical environment that 
controls stem cell fate. Most of the ceramic biomaterial scaffolds used in perfusion bioreactors 
are calcium phosphate with a chemical formula similar to that of natural human bone .Synthetic 
calcium phosphate scaffolds have also been used to host a variety of orthopedic cells, such as 
osteoblasts, endothelial cells and mesenchymal stem cells (MSC) in in-vivo bone implants44,45,46.  
Hydroxyapatite (HA) and β- tricalcium phosphate (TCP) are the main phases that have been used 
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to culture human mesenchymal stem cells and shown to induce bone formation47,48,49. Also, in 
the vivo models, calcium phosphates are reported for bone repair and bone graft substitutes. HA 
has been found to exhibit excellent biocompatibility with osteoblasts, which forms bone tissue. 
HA can also: induce the osteoblast cells and react with osteoclast cells, resulting in the secretion 
of new apatite on the surface after implantation into body50. Researchers also found that HA 
could be used as an excellent carrier for osteo-inductive growth factors and osteogenic cell 
populations51.  HA could also be used as a DNA carrier and suggests utility as a bioactive 
delivery vehicle. Another commonly reported calcium phosphate used for bone hard tissue 
regeneration is TCP. Jarcho52 reported an in-vivo experiment in which TCP completely resorbed 
in six weeks. Other groups53,54 reported that biphasic calcium phosphate, containing HA and 
TCP, achieved a desirable degradation rate and mechanical properties while bone tissue was 
regenerated during the resorption of scaffold. The ratio of HA to TCP in these studies varies a lot 
with 60% HA / 40% β-TCP being the ratio most commonly reported55, 56. 
Calcium phosphate scaffolds have also been used in tissue engineering of bone marrow.  
For example, an HA scaffold was used for loading regenerated bone marrow and was tested in a 
mouse model in terms of its ability to reconstitute the functionality of bone marrow niche57. In 
the mouse model, the results suggested that the functional niche was reconstituted at least partly 
from regenerated bone marrow on the scaffold. Those studies demonstrate the possibility of 
culturing hematopoietic stem cells (HSCs), an important bone marrow stem cell population, on 
calcium phosphate ceramics. In this proposal, HSCs will be cultured in-vitro, on calcium 
phosphate ceramics with different bone marrow cells such as endothelial cells and osteoblast 
cells in an attempt to co-culture the bone marrow stem cell niche. 
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2.2 BONE MARROW 
As one of the most important part of body, bones support and protect the various organs of the 
body and store minerals. The large bones also house the bone marrow cavities in which blood 
cells and the cells for the immune system are produced.  Bone marrow has two extracellular 
components, organic and inorganic. The organic part of bone tissue is mainly collagen, with 
various growth factors. The composition of the inorganic mineral component can be 
approximated as hydroxyapatite (HA), with the chemical formula Ca10 (PO4)6(OH) 2  with a Ca/P 
ratio of 1.6758. However the Ca/P ratio in the mineral phase of bone varies from 1.37 to 1.87.  
This phase is secreted by osteoblasts during biomineralization and contains additional ions such 
as silicon, carbonate and zinc in solid solution59. The remodeling of the bone structure continues 
over the whole lifetime of a human by the bio reactions in which osteoclast cells resorb bone and 
the osteoblasts secret new bone mineral60. 
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Figure 2.3 Bone structure61 
As depicted in Figure.2.3, bone is not an uniform solid material, in fact, bones are quite 
porous, and can be separated into two types of structure:, compact bone and the trabecular bone. 
The compact or cortical bone that surrounds  the central marrow, forms a hard outer layer and 
provide 80% of the bone mass in adult humans due to its relatively low porosity ( 5 -30%)62.The 
cortical bone tissue provides the high strength and high stiffness required to protect the central 
bone marrow cavity and provide suitable skeletal properties. 
The other major bone structure is trabecular bone, which fills the interior of the large 
bones and is characterized by its open cell porous network structure. The open honeycomb 
structure of trabecular bone tissue houses the bone marrow and the blood vessels that perfuse the 
bone marrow with blood. The porosity of trabecular bone is in the range 30–90% and the surface 
area is ten times that of compact bone while the mass is only one fourth. Bone marrow is the soft 
tissue in the trabecular bone and constitutes 4% of the total body mass of humans63. It has an 
important function in the formation the blood cellular component by a process known as 
hematopoiesis. Bone marrow is also regarded as an important part of the lymphatic system, 
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producing the lymphocytes that support the body's immune system64.The bone marrow can be 
separated into two types, red marrow or medulla ossium rubra, which mainly consists of 
hematopoietic tissue; and yellow marrow or medulla ossium flava, which mainly contains fat 
cells. All the bone marrow is traversed by a blood vessel and a capillary network. 
2.2.1 Hematopoietic Stem Cell 
Of the two types of marrow, the red marrow is the one that controls and contributes cells 
to the blood and lymphatic system. In the red marrow, hematopoiesis occurs continuously 
throughout life. Hematopoietic stem cells (HSCs) are the cells that are of central importance to 
hematopoiesis and the formation of hematopoietic tissue in red marrow.  HSCs have ability to 
replenish all cellular components of blood and self-renew. In order to maintain steady-state 
levels in the peripheral circulation, the HSCs produce 1011–1012 blood cells per day in a healthy 
human adult and use the bone marrow vasculature as a conduit to the body's systemic 
circulation65. In bone marrow, the blood vessel network, lined by endothelial cells, plays an 
important role in supporting the nutrition and renewal of differentiated mature blood cells. Those 
blood cells includes: erythroid cells for carrying oxygen, myelocytes such as monocytes and 
macrophages, and lymphocytes lineages for the adaptive immune system, such as T-cells, B-
cells66. 
In the first step of the HSCs differentiation process, which is shown in Figure 2.4, the 
specific progenitors are induced from the HSC population. In asymmetric division, small 
numbers of the self-renewable HSCs can divides into a large number of cells while a part of the 
population remain as HSCs keeping the pool of stem cells available. The other daughter HSCs 
will be induced into myeloid or lymphoid progenitor cells in alternative pathways67. Those 
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progenitors don’t have the ability of self-renew but could lead to the specific types of mature 
blood cells, which will be released to the body’s circulation through blood vessels in bone 
marrow. 
Additionally, the pool of HSCs itself is heterogeneous and can be classified as long-term 
self-renewing HSC and short-term self-renewing HSC68, which depends on the long-terms or 
short-terms regeneration capacities. Self-renewal is one of the most vital processes in the body 
and is also a cornerstone for hematopoietic stem cell transplantation in which a small amount of 
HSCs is used to reconstruct a new functional hematopoietic tissue system. The two types of 
HSCs with different regeneration capacities reside in the endosteal niche and the vascular niche. 
The endosteal niche is next to the trabecular bone surface, where the HSCs renew and also 
remain dormant. In this niche, HSCs are thought to favor long-term self-renewal and their 
multipotent capacity remains to give a HSC reservoir. The other type of niche, the vascular 
niche, exists near blood vessels in which HSCs would differentiate and recover blood cells in a 
relative short time when needed. After the differentiation, the blood cells would go through the 
vascular wall and released into the body’s blood stream. 
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Figure 2.4 Hematopoietic and stromal stem sell differentiation69. 
2.2.2 Hematopoietic Stem Cell Applications 
As a component of the first stem cell therapy, bone marrow stem cells have been used for the 
treatment of blood and immune system disorders for more than 50 years. Since then, more than 
half a million people have undergone routine HSC stem cell transplantation 70 .These HSC 
transplantation therapies have been used to treat: multiple myeloma or leukemia 
patients 71,72,including those with severe combined immunodeficiency or congenital neutropenia 
with defective stem cells, aplastic anemia 73 , sickle-cell disease, myelodysplastic syndrome, 
neuroblastoma, lymphoma, Ewing's sarcoma, desmoplastic small round cell tumors, chronic 
granulomatous disease and Hodgkin's disease.  
HSC transplantation can be split into two types, autologous and allogeneic. Both types of 
therapies have been used for numerous patients all around the world. Autologous HSCT requires 
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the HSC source from the patients themselves. After being extracted from the patient, the cells are 
sorted and the HSCs are frozen and stored. After the disease is treated with high-dose 
chemotherapy or radiation treatment, the patient's immune system will be compromised by either 
the partial or the complete bone marrow ablation required to kill the aberrant disease-causing 
immune cells.  Then the stored stem cells are unfrozen and transplanted back into the patient in 
order to replace the destroyed hematopoiesis tissue. The transplanted HSCs are required to 
regenerate a new and antigen-naive immune system and resume the patient's normal blood cell 
production 74 . Autologous transplants have the advantage that the patients rarely experience 
rejection and the risk of infection during the chemotherapy  treatment process is lower75. 
Allogeneic HSCT involves donated cells and the donor and the recipient must be matched by 
gene typing. Special blood tests are done to test the human leukocyte antigen (HLA) gene type 
match. HLAs are the major cause of organ transplant rejections76 so that allogeneic HSCT 
prefers a perfect match at the loci of HLA gene between the donor and the recipient. Even if 
these critical alleles are matched well between the donor and the recipient, there is still a risk of 
graft-versus-host disease and immunosuppressive medications are required for the recipient. 
Allogeneic HSCTs could have improved likelihood of a cure and long term remission since 
healthy stem cells are transferred to reform the immune system; however, the immediate 
transplant-related complications are the main obstacle of concern77.This roadblock could be 
addressed if the HSC population could be proliferated in bioreactors since the cell population 
growth could enrich the HSCs in transplantation and shorten the time that is required to recovery 
of immune system. In one study conducted by the European Group for Blood and Marrow 
Transplantation from 1993 to 2003, the patients who received autologous hematopoietic stem 
cell transplantation, 420 patients (89%) were alive and 53 patients (11%) had died: 31 (58% of 
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deceased patients) due to transplant-related causes and 22 (42% of deceased patients) due to 
disease progression.  Amongst all of these the highest mortality was caused by infections (N=16; 
50%)78. 
According to the hypothesis of this proposal a new type of hydroxyapatite foam could 
enhance the HSCs proliferation and expand the population in bioreactors, the HSCs read 
ministered to patients in transplantation could thereby be enriched and shorten the time of 
immune system recovery, leading to decreased risk of infection and higher survival rates. 
Besides the traditional hematopoietic stem cells application, such as HSC transplantation, 
researchers are also showing great interest in in-vitro culture of hematopoietic stem cells for 
other reasons Recent reports have suggested that hematopoietic stem cells could form other kinds 
of cells, such as muscle79 , blood vessels80 and hepatocyte tissue81 in in-vivo models. The results 
lead to another possible direction for the use of HSCs in regenerative medicine, namely the use 
of hematopoietic stem cells to replace specific tissue and organ82. 
2.2.3 In vitro Hematopoietic Stem Cell Culture 
The Hematopoietic stem cells (HSC) have been unquestionably important to therapies that 
involve blood and immune system replacement. However, the in-vitro culture and the expansion 
of HSCs are still roadblocks on expand the application of HSCs. The proliferation of HSCs is 
being researched for suitable conditions. There is a report by Lagasse and Weissman 83 
concerning the failure and difficulty in culturing HSCs alone by in-vitro culture. Most of the 
stromal cell lines that were shown to maintain HSCs in vitro, contained osteoblasts84,85, and 
would be relevant to the endosteal bone-marrow niche. Recently, a research group also proposed 
the successful co-culture of mice HSCs with stromal cells and cytokines86. Even though there is 
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a hypothesis that osteoblasts are necessary and rate-limiting for the niche function87,88, other cell 
types, such as endothelial cells, stromal fibroblasts, are also attributed to HSC niche and might 
be important to HSCs in-vitro culture89. Another important consideration is the vascular bone-
marrow niche, mentioned above. In this niche model, there is also success on HSC in-vitro 
culture. Embryonic precursor endothelial cells or purified primary endothelial cells from the yolk 
sac or aorta-gonad-mesonephros were reported to promote the maintenance or expansion of 
HSCs in vitro90,91,92. However, there is no capability for vascular endothelial cells from adult 
non-hematopoietic organs to maintain HSCs in vitro culture93. 
In this proposal, therefore,, it is important to determine the effects of the new scaffold 
material on different cell types that are known to reside in bone marrow, and consider co-cultures 
with HSCs on the scaffold material. 
2.3 CALCIUM PHOSPHATE 
2.3.1 Calcium Phosphate 
Calcium orthophosphates are of interest in many scientific fields, such as geology, chemistry, 
biology and medicine. They form a large family of phases which shares the same constituent 
elements of calcium, phosphorous and oxygen.  Calcium phosphates can also incorporate 
hydrogen as acidic orthophosphate anion or water94.  
We can distinguish the calcium phosphates by the type of the phosphate anion: ortho- 
(PO43−), meta- (PO3−), pyro- (P2O74−), and poly- ((PO3) nn−). Meanwhile, the calcium phosphates 
with multi-charged anions (orthophosphates and pyrophosphates) can be differentiated by the 
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number of hydrogen ions attached to the anion94. For example, there are several calcium 
phosphates used in bioceramics, including: mono- (Ca (H2PO4)2), di- (CaHPO4), tri- (Ca3 
(PO4)2), and tetra- (Ca2P2O7) calcium phosphates95,96,97.  
In these examples, it is clear that the atomic arrangement of calcium orthophosphates is 
based on a network of orthophosphate (PO4) groups that leads to structure stability. The vast 
majority of calcium orthophosphates are sparingly soluble in water; however, all of them are 
easily soluble in acids and relatively insoluble in alkaline solutions. In all mammalian calcified 
tissues, biological formed calcium phosphates play an important role in bones, teeth and antlers 
and also pathological (i.e. those appearing due to various diseases) calcified tissues of 
mammals98.  
Bones in the human body could be separated into organic and inorganic as mentioned 
before. Calcium orthophosphate has a similar chemical make up as inorganic bone tissue. In 
orthopedics and related areas of medicine, the calcium phosphates are widely used because of the 
good compatibility, non-toxicity and bioactivity99.Also, as mentioned earlier, synthetic calcium 
phosphates can be fabricated as a scaffold for bone regeneration that support the adhesion and 
proliferation of osteoblasts100,101.In such cases, osteo-integration, a bone remodeling process, can 
occur on the surface of calcium phosphates which facilitates bonding  between implants and 
bone102,103. 
Also, in the processes of demineralization and biomineralization, calcium phosphates 
with other Ca/P ratio are reported, including: octaclacium phosphate (OCP), brushite and 
whitlockite (β-TCP). 
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2.3.2 Hydroxyapatite 
The chemical formula for hydroxyapatite is Ca5 (PO4)3(OH), but it is usually written Ca10 
(PO4)6(OH)2 to emphasize the fact that the crystal unit cell comprises two formula 
units104.Hydroxyapatite is a hexagonal material, with space group P63/m,  and a total of  44 
atoms per unit cell 105 . HA has a calcium-to-phosphate ratio of 1.67 while the unit cell 
dimensions are a=b=9.432Å and c=6.881Å. The structure of an HA unit cell is shown in Figure 
2.5. 
 
Figure 2.5 HA unit cell structure 
The OH- ion can be replaced by fluoride, chloride or carbonate ions producing 
fluorapatite or chlorapatite 106 . Pure hydroxyapatite powder is white but naturally occurring 
apatites can, also have brown, yellow, or green colorations, comparable to the discolorations of 
dental fluorosis.  Hydroxyapatite is a member of CaO-P2O5-H2O system.  The ternary 
compositional diagram for this system is shown in Figure 2.6.  It can be seen that hydroxyapatite 
(HA) lies on a tie line between calcium hydroxide (Ca (OH)2) and tricalcium phosphate 
(3CaO·P2O5)107. 
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2.3.3 Tri-calcium phosphate 
Tri-calcium phosphate (TCP) has three polymorphs, β-TCP, α- TCP and α′-TCP. α′-TCP only 
exists in equilibrium at temperatures higher than 1430 ºC and converts back  to α-TCP on 
cooling below the transition temperature. β-TCP and α- TCP can exist at room temperature 
although the equilibrium phase transition between β-TCP and α- TCP occurs at ~1125°C108.  
β-TCP, β-Ca3(PO4)2 , has the rhombohedral space group R3 c, Z=21, which unit cell a= 
b=10.4352(2) Å, c=37.4029(5) Å, gamma=120° in the hexagonal setting. There are 21 formula 
units per hexagonal unit cell and 5 Ca2+ sites with three types of crystal graphically non-
equivalent PO43- groups located at general points of the crystal in the unit cell. The 5 types of 
calcium environment are shown in Figure 2.7. 
Figure 2.6 CaO-P2O5-H2O Phase Diagram 
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Figure 2.7 Calcium environments of Ca1 site (a), Ca2 site (b), Ca3 site (c), Ca4 site (d) and Ca5 site (e) in 
the β-TCP structure109 
β-TCP has a higher solubility than HA and can be degraded more rapidly in the body110. 
Hence, β-TCP is applied as a bone tissue scaffold and shows outstanding biological responses to 
physiological environments111. Amongst others Gibson et al proved that implanted β-TCP could 
be resorbed in vivo with new bone growth112. β-TCP also showed excellent bioactivity and 
biocompatibility in in-vitro culture of bone marrow stromal cells culture towards osteogenic 
differentiation113. 
α -TCP, α -Ca3(PO4)2 , has the same chemical formula as β-TCP but a monoclinic space 
group , P21/a .There is 24 formula unit in the unit cell, which a= 1.2859(2) Å b= 2.7354(2) Å, c= 
1.5222(3) Å, β=126.35(1)°,α=γ=90°.Compare with β-TCP, α-TCP is a less densely packed 
structure and accordingly is expected to have a higher solubility and degradation rate during in 
vitro and vivo culture , which are consisted with the experiments. In Figure 2.8, β-TCP and α- 
TCP structure were shown in Ca2+ and P5+ type. 
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Figure 2.8. Disposition of constituent atoms in β-TCP, α- TCP: Ca2+, green; P5+, magenta; O2− has not been 
represented.  a) Along the [001] direction b) along [010] direction114 
 
In clinical applications, β-TCP is used as macro-porous granules or blocks and plays an 
important role in mono-phasic or biphasic bio-ceramics and composites114, while α-TCP is 
generally used only as a fine powder for calcium phosphate cements, such as hydraulic bone 
cements115,116, because of its higher solubility.  
Tri-calcium phosphate has been provided to have excellent properties in clinic 
application, such as dentistry, orthopedic surgery, and bone regeneration and repair. 
2.3.4 Solubility of Calcium Phosphate Phases 
Calcium phosphate can be remodeling by the osteoblast and osteocytes in biological process. 
However, these materials will dissolve chemically in aqueous solution.  Indeed, the rate at which 
calcium phosphate scaffold materials will degrade is often measured, to a first approximation, in 
terms of their chemical solubility. In the dissolution process, calcium ions and phosphate ions are 
released from the ceramic scaffold into the solutions and influence the cell culture environment.  
Calcium in particular is known to effect cells that reside in the bone marrow niche cells, such as 
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osteoblasts117 and endothelial cells. Therefore calcium released by a calcium phosphate scaffold 
should affect the HSC niche and HSC fate.   Thus the solubility of calcium phosphates will be 
important to culturing HSCs on calcium phosphate scaffolds in bioreactors.  
Several studies have been performed on calcium phosphates in different 
solutions84,85, 118 ,which compared calcium phosphate solubility in different environment 
conditions. A study by M.Bohner showed most of the calcium phosphates and calcium phases, 
which provided an important foundation for this proposal. In Figure 2.9, the solubility of those 
calcium phases, which might infect the proposal, is compiled in one graph except Ca(OH)2. 
Calcium hydroxide has solubility as high as 1.25E-2mol/L in pure water. And in tris-buffer, 
calcium hydroxide has solubility larger than 1 mol/L, which is too high to be easily compared 
with other calcium phases. 
 
Figure 2.9 Solubility isothermal of Calcium Phosphates in water119,120 
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In Figure 2.9, solubility of calcium phosphates with different Ca/P ratio has been shown 
as a function of pH. As Figure 2.9 showed, calcium phosphates have a wide range of solubility 
that range from 10-1 to 10-5 at PH=7~8 in water. MCPM, Mono-calcium phosphate monohydrate, 
has a Ca/P =0.5 has the largest solubility, which is too high for in-vitro bone tissue culture. 
Besides MCPM, other Calcium phosphates and the Calcium carbonate have more suitable 
solubility for scaffold degradation.  At pH=7.35 to 7.45 range, which is general bone marrow 
culture pH condition, calcium carbonate had a solubility range at around 10-2.5 and would release 
the most amount of Ca+2 ions into the solution. Then it was followed by Tetracalcium phosphate 
(TeCP) and one phase of the tricalcium phosphate, α-TCP. The solubilities of these two phases 
are about the same at pH=7.4. The solubility of the CaP phases decreases in the order: Dicalcium 
phosphate dehydrate (DCPD) > Dicalcium phosphate (DCP)> Octocalcium phosphate (OCP)> 
low temperature phase of tricalcium phosphate, β-TCP, and finally HA. 
According to the graph, HA has the solubility which is around 10-5 and is not considered 
to resorb fast enough in vitro or in-vivo conditions with little Ca2+ released, it dissolves slower 
than the mineral part of bone83.HA has good biocompatibility and bioactivity for tissue 
remodeling but the Ca2+ release is very low. In the studies, researches have successfully 
increased HA dissolution by different techniques121,122. However, those techniques decreased the 
Ca/P ratio. 
2.3.5 Effect of Calcium on the Bone Marrow Niche 
In bone marrow in-vitro culture, the activity and the bone remodeling by osteoblasts is 
considered to be of particular importance. However, angiogenesis and vascularization with 
endothelial cells will also play a vital role. Angiogenesis, which is not much different with 
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vascularization, is the physiological process through which new blood vessels form from pre-
existing vessels 123 . In wound healing, functional tissue recovery, and granulation tissue 
formation, angiogenesis is a normal and vital process in tissue growth and development124. After 
the angiogenesis process, the vasculature becomes mature and functional, leading to the 
vascularization process finishing. 
As mentioned, vascularization plays a crucial role in 3D cell cultures. The capillary 
vessels, lined by endothelial cells, allow vascular transportation of nutrients to the cells and takes 
cell waste to external environment.  Endothelial cells are expected to reside in the HSCs niche 
for their vascularization potential and vascular niche model has been used to successfully co-
culture with HSCs125,126. As common cell type in the bone marrow, osteoblast cells are also 
considered to be essentially for controlling the fate of HSCs. It has been found that osteoblast 
cells could secrete proteins that help in HSCs localization at the endosteal surface127,128,129 and 
help adhesion to the matrix 130 .Notably, Nakamura et al 131  showed that calcium ion 
concentrations effect osteogenic differentiation and protein expression of osteoblast cells. And 
the Ang protein expressed by osteoblasts was found to play a pivotal role in controlling HSCs’ 
fate. The result suggests that Ca concentrations released from scaffold materials might be used to 
control HSC fate in bone marrow in-vitro culture.   
In the present work, it is proposed that ceramic foam will be used to elevate the release 
Ca ions in the in-vitro bone marrow niche and induce HSCs proliferation. 
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2.4 CERAMIC FOAM 
In order to mimic the microenvironment of the HSCs endosteal niche in the body, this study will 
process scaffold material with a similar structure and chemistry to trabecular bone but with 
higher Ca concentration than existing in pure synthetic hydroxyapatite. The scaffold should 
provide a temporary support for the cells, allowing them to attach to the scaffold surface and 
should provide a chemical environment similar to trabecular bone .The open foam structure will 
allow for the nutrients in culture to be transferred to the cells and the waste to be removed.  The 
most suitable structures are macroporous calcium phosphate foams with high pore fractions 
(greater than 80%) and large open pore architectures.  The methods used to process macroporous 
ceramics will now be reviewed. 
Foam is one type of the cellular ceramics, which are comprised of various arrangements 
of a space-filling polygon (cells) 132and could satisfy the requirement of three-dimensional cell 
culture. 
Porous ceramics can be produced by numerous processing methods, commonly separated 
into three main categories by the principle used in their preparations133. They include replication, 
templating and direct foaming, as it is shown Figure 2.10. 
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Figure 2.10 Scheme of possible processing routes used for the production of macroporous ceramics134 
2.4.1 Replication 
Replication is a method that coats a polymeric sponge with a ceramic particulate suspension and 
removes the polymer foam during controlled heating, the particles then sinter into a rigid copy of 
the polymer foam135.136. In this replication method, a variety of ceramic cell types could be 
processed, including open- cell, semi-closed cell and closed-cell123. The ceramic pore or cell 
sizes are determined by the polymer sponge pore size and to a limited extent by the shrinkage in 
the sintering step. 
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As one of the most commonly used processing method since 1963, replication could be 
used on many polymer materials. The desirable properties of the polymer foam for the 
replication process include: (i) volatilization at low temperature without yielding noxious by-
products, (ii) softness at the coating temperature, (iii) burning off of the polymer without 
inducing significant residual stresses and disrupting the unsintered ceramic, (iv) hydrophobic 
behavior, and its ability to be uniformly covered network123. Many polymers have been found to 
be suitable for replication including polyurethane, cellulose, polystyrene, etc. Perhaps the most 
commonly used polymer is polyurethane which has been shown to be capable of controlled pore 
size and morphology137. 
In replication, the slurry is formed by a ceramic powder with a dispersion medium, which 
can be aqueous or non-aqueous. Commonly, some additives are added to the slurry to enhance 
stability and uniformity of coating.  Replicated ceramic foams are distinctive in that the core of 
the foam struts is hollow due to the original polymer foam.  The walls of the foam can also be 
cracked by the burn out process.  Both of these features tend to compromise the strength and of 
the foam and render them fragile at high porosities 
 
2.4.2 Templating 
In the templating, or sacriﬁcial template method, the initial biphasic mixture consists of a 
continuous matrix of ceramic precursors and a dispersed sacrificial phase, which should be 
homogeneously distributed in the matrix125. In this template method, the sacrificial phase aims to 
generate pores as a negative replica, as shown in Figure 2.10. 
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There are generally three methods to prepare the biphasic mixtures in templating 
ceramics 138 :  the first one is mixing the two component powders and the compaction by 
pressing139; the second method creates a two phase suspension that is subsequently processed by 
wet colloidal routes such as slip, tape or direct casting140; and the third method is impregnating 
previously consolidated preforms of the sacrificial material with a pre-ceramic polymer or 
ceramic suspension141. 
The sacrificial material plays an important role as a pore former and controls the pore 
size, connectivity, pore distribution and other properties. There are many suitable particulate 
sacrificial materials including organics, salts, metals, ceramics and even some types of liquids129.  
2.4.3 Direct Foaming 
The third route for processing macro-porous ceramics is direct foaming, in which air or another 
gas is dispersed into a suspension to create bubbles while the liquid phase, commonly a 
suspension of ceramic particulates, is used to keep the structure and form of the material129. As 
Figure.2.10 (c) shown, the mixing between the gas phase and the liquid suspension determine the 
resultant porosity. The stability of the bubbles is the most important factor. After setting, the 
foam is generally dried at room temperature and then sintered  
The critical issue in direct foaming is the stability of bubbles during drying due to 
drainage of the liquid through the liquid strut network under gravity. It is known that liquid 
foams are thermodynamically unstable systems and there is several physical processes taking 
place at their high gas–liquid interfacial area to decrease the high free energy129. Those physical 
processes can be of benefit to increasing the pore size, but rapid Ostwald ripening can remove 
many of the struts and collapse the foam129. 
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In order prevent coarsening and stabilize the foams, surfactant and biomolecules can be 
added to the liquid and have been found to slow down this coarsening process by decreasing the 
interfacial energy. Pugh 142  proved that foam bubbles coated with long-chain surfactant by 
adsorption could survive for several hours longer than without surfactant. 
There are two methods that can be successfully used to achieve foaming stabilization129; 
one is stabilization with surfactants while the other is stabilization with particles. 
In the surfactant stabilization, long-chain molecules with amphiphilic property and 
biomolecules such as lipids and proteins are used to make the wet foam stable. Those molecules, 
can act as surface-active agents to decrease the free energy between the hydrophilic phase and 
hydrophobic phase and preserve the interfacial area. In effect the molecules are adsorbed at the 
gas bubble surface, reduce the interfacial energy, and slow down the coalescence. However, the 
surfactant could not prevent the long-term destabilization and it is hard to increase the wet 
foaming time beyond several hours. 
In the other stabilization method, solid particles are used to impede the destabilization 
and enhance the wet foaming time significantly, which could be several days143.In this method, 
the colloidal particles are used in Pickering emulsions to stabilize high energy interfaces144 and 
have been applied to ultra-stable wet foams preparation145,146. 
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Figure 2.11 Scheme of foams and mists that can be produced through the adsorption of colloidal particles 
at the gas–liquid interface. The drawings on the right hand side indicate the force balance at equilibrium for particles 
lyophobized to different extents129 
As it is shown in Figure.2.11, the particles attach to both gas and liquid phases if they are 
partially hydrophobic. In this case, the high energy interface between gas and liquid is replaced 
by the lower energy boundaries of solid-gas and solid-liquid interfaces. With the particles added, 
the contact angles between solid and liquid phase is > 90°, while the gas and solid phases have a 
contact angle <90°. 
The contact angle of the particles could determine the dispersion of the phases147 and act 
as one of the free energy determine factors. In this condition, the energy of attachment or free 
energy gained (G) by the adsorption of a particle of radius r at the interface can thus be 
calculated using simple geometrical arguments, which lead to the equation 2.1 and 2.2138: 
G = πr2γLG(1-cosθ) for θ<90°   eqn 2.1  
G= πr2γLG(1+cosθ) for θ>90°  eqn 2.2 
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Where θ is the contact angle and γLG is the gas-liquid interfacial tension. 
In the particle stabilization method, foam with smaller pores and higher pore fractions 
can be made.  The typical porosity of these macro-porous structures range from 40% to 93% 
while the average pore sizes are much lower than those formed by the surfactant method formed 
pore sizes, in the range 10 to 300 µm. 
2.4.4 Emulsion Foaming 
An open porous ceramic, which has porosity as high as 97%, was created by Barg et al148 
using emulsifying aqueous suspensions of heptane containing ceramic powders and cationic or 
anionic surfactant. These ionic surfactants help to stabilize the bubbles in the emulsion using 
repulsive force between lyophilic end of molecule and the bulk liquid. This repulsive force helps 
to control the bubble development during the evaporation of volatile alkane and create porosity 
ceramic foam. 
In this proposal, the foams are made in a similar method as Barg et al, and porosity is 
approximately 90% with the average pore size 500µm. This structure is suitable for cell seeding, 
cell growth, and nutrient transportation in the bioreactor application. 
2.5 SINTERING 
Sintering is an important thermal treatment step for ceramic fabrication. Ceramics 
commonly require sintering at temperature lower than the melting point, which allows mass 
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transport to eliminate by solid state sintering in response to the thermodynamic driving force 
provided by the elimination of pore surface. 
There are three stages of microstructural evolution during the sintering process149: In the 
initial stage of sintering necks form to connect neighboring particle and the necks will grow but 
remain discrete.  The growth of the necks causes center to center approach of the particles. This 
stage will result in some shrinkage (Figure 2.12) but ends at the relative density of about 65% of 
the “theoretical when the necks begin to overlap150.  Initial stage sintering usually occurs during 
heating to the sintering temperature. 
 
Figure 2.12 sintering stage model 151 
In the second or intermediate stage, the microstructure is a network of connected grains 
and pores. During this stage, the stage the pores continue to shrink but remain open to the 
environment as shrinkage continues by neck growth. The intermediate stage is the stage in which 
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most of the sintering shrinkage takes place.  Again much of this stage will occur during heating 
to the sintering temperature. 
The final stage of sintering is characterized by the pore channels pinching off to give 
isolated pores.  It begins at a relative density of approximately 90%.   The sintering rate is now 
quite slow and full density is only achieved by the elimination of all the isolated pores. 
2.5.1 Infiltration 
Porous ceramics can be successfully infiltrated by a second phase through pores that are 
connected to the exterior surface if they are first sintered into the initial stage or intermediate 
stage sintering.  These phases can be introduced as liquids, resins or particles in suspensions152. 
In all cases the infiltration processes are characterized by flow of a fluid through a porous 
ceramic that has been sintered into the initial stage or the intermediate stage of sintering. During 
the infiltration process, the pores and the voids of the solid-phase powder compact are filled by a 
wetting liquid that displaces gas that is residing in the pores. The force and the energy that draw 
the fluid inward are the capillary force and the reduction of the surface-free energy. 
In the infiltration process, the ceramic should provide a system of interconnected pores 
and channels that allow the infiltrant penetration. The infiltration process can provide unique 
microstructures, with relatively broad control of both the depth and the composition of the 
infiltration modified zone55.Infiltrations have been used for preparing multiphase ceramics in 
several studies. Marple and Green153 fabricated alumina / mullite ceramic and pointed out that 
infiltration approaches could control the phase distribution and the microstructure development. 
After partial sintered at 1300°C, the alumina cylinder compacts were immersed in prehydrolysed 
ethyl silicate solution for different times, dried and heated at 1200°C to allow decomposition of 
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the ethyl silicate. Finally, mullite was formed and the compacts were densified during a final 
heating step at 1650°C. Similarly, Lin et al154 cyclically infiltrated porous zirconia with a mullite 
precursor liquid solution. In the cyclic process, the maximum amount of mullite precursor 
infiltrated depended on the initial open porosity of the matrix.  The distribution was non-uniform, 
with higher mullite concentration near the surface external surface. After the infiltration and 
sintering, the gradient in second phase created residual stresses and cracking on cooling. This 
residual stress is thought to arise because of differential thermal expansion155.  
In the preliminary work for this proposal, calcium nitrate solution was infiltrated into 
porous HA foam. Then the foam was immersed in ammonium hydroxide to give in-situ 
formation of CaO particles in the HA foam before final sintering. 
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3.0  HYPOTHESIS 
In the past decades, synthetic calcium phosphate has become an important biomaterial for hard 
tissue growth in-vivo. The ratio of Ca/P varies with the different phases and this has been 
reported to affect bioactivity and biocompatibility. Hydroxyapatite with Ca/P=1.67 is reported to 
enhance bone marrow cell culturing. Recent studies have shown that high calcium content in the 
media can enhance ostegenesis (growth of new bone) and angiogenesis (growth of new blood 
vessels).  The hypothesis of this work is that composites of HA and CaO can increase the release 
of Ca into the media surrounding bone marrow cells and thereby promote HSC expansion and 
endothelial cell growth.  If this can be achieved it would show, for the first time, that a scaffold 
could be manipulated to control stem cell fate during in-vitro culture that seeks to recreate the 
endosteal niche in which a population of HSCs could be expanded over the course of 4 weeks of 
culture. 
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4.0  OBJECTIVES 
1. Partially sintered HA foams were infiltrated with calcium nitrate precursors to produce. 
CaO or CaCO3 phase in-situ. The effect of the calcium nitrate concentration on 
infiltration, CaO or CaCO3 phase fraction and the spatial distribution of the phases will 
be studied in pellets and foams. 
2. Determine the time frame over which calcium is released into the media from the 
infiltrated ceramics. The solubility of infiltrated foam will be measured in static 
conditions.  
3.  Determine the effect of Ca content on endothelial cell and osteoblast / HSC population in 
static cell culture. After the examination of the infiltrated foam biocompatibility on 
endothelial cells and osteoblasts, it is necessary to determine the effect on HSCs, which 
was co-cultured with osteoblasts. 
4. Examine the microstructural mechanism by which the dissolution of the Ca rich phase 
controls the fragmentation of the microstructure and the possible loss of structural 
integrity of the scaffold. 
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5.0  APPROACH 
5.1 MATERIAL PREPARATION 
5.1.1 Hydroxyapatite Powder Preparation 
In order to ensure the phase purity, hydroxyapatite powder was calcined at 900°C for 1 hour. 
After calcination, the powder was milled in water for 24 hours and was dried and granulated 
again by pestle and mortar. 
5.1.2  High Calcium Content Pellets 
After the powder preparation, the hydroxyapatite powder was pressed into 13mm diameter 
pellets at a pressure of 26 MPa pressure. The resulting green density was 49.5%. After pressing, 
the pellets were sintered in air at 1100°C for 1 hour, using a heating rate is 5 °C/min  and a 
cooling rate at 10 °C/min. After partial sintering, the relative density was 67%. 
The infiltrant was prepared from calcium nitrate tetrahydrate (Ca (NO3)2·4H2O, Alfa 
Aesar, England) with water. The solution concentrations were prepared with Ca 2+ concentrations 
of 0.5 mol/L, 1 mol/L and 2 mol/L. The pellets were then evacuated to remove the air from the 
pores and immersed in the calcium nitrate solution. After 24 hours the pellets were remove from 
the calcium nitrate solution and drops of ammonia hydroxide solution with pH=12-13 were 
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placed on to the surface of the pellets followed by immersion in ammonium hydroxide solution 
for 30 minutes before drying in air at room temperature for 24 hours. The pellets were heat 
treated at 900 °C to achieve crystallization of CaO in the infiltrated pellet 156 . The average 
calcium to phosphate ratio in the hydroxyapatite pellets was higher than that of HA (1.67). Then 
the hydroxyapatite pellets were sintered to high density at 1300 °C for 1 hour to remove the pore 
space and to make sure the porosity that remains was closed. The heat rate was 5 °C /min while 
cooling rate is 10 °C/min.  The mass changes were recorded after each step of process. During 
the whole process, control samples were made in the same processing steps except for infiltration 
5.1.3 High Calcium Phosphate Ratio Foam 
In order to create a high calcium content ceramic foam, a HA ceramic foam was created by 
emulsion method and infiltrated with Ca2+ solution in the following process. 
The HA foam was prepared by an emulsion process. A suspension was made by mixing 
deionized water with HA powder prepared as described above with 30 vol% solids. Ammonium 
polymethacrylate polyelectrolyte dispersant (Darvan C, RT Vanderbilt Co.) was then added to DI 
water and adjust pH to 5.5 by HCl solution. In this pH condition, a cationic surfactant 
(benzethonium chloride, Sigma) was active and could stabilize the alkane droplets by forming 
critical micelle concentration layers.  After adding the HA powder the suspension was mixed at 
2500 RPM for 20 minutes, in order to get proper dispersion. After the high speed mixing, the 
cationic surfactant (benzethonium chloride, Sigma) was added to the emulsion and mixed at 
2500 RPM speed for 2 minutes. The final step was the addition of 10% volume of heptane to 
create bubbles and then mixed at high speed for 2 minutes.  
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In order to make the foam expand and form connected pores, the emulsion was poured 
into a paper mold in an incubator with 60% humidity for 1 hour and then the humidity was 
decreased to 40% until the foam had fully dried. The mold was then fired in furnace to 900 °C 
using 2 °C/min heating rate and a 10 °C/min cooling rate. 
The foams were sintered in air at 1000 °C for 1 hour, using a heating rate is 5 °C/min 
with cooling rate at 10 °C/min. Then the infiltration procedure is similar to the pellets infiltration 
process as described before.  After being infiltrated with Ca2+ solution  at  0.5, 1 or 2 mol/L, the 
foams was immersed in ammonia hydroxide solution at pH=12-13 to precipitate Ca(OH)2 .After 
drying the foam was fired at 900 °C to achieve in situ-crystallization of CaO in the pores, and 
then sintered to high density at 1300 °C for 1 hour. In this process, the pores between the HA 
particles are closed leaving the CaO inside the foam walls.  The heat rate for sintering was 
5 °C/min while the cooling rate was 10 °C/min. 
5.2 CHARACTERIZATION  
Previous impregnation studies produced gradients in the infiltrated phase from the external 
surface155. It is therefore necessary to identify the second phase(s) attributable to the 
impregnation process and their distribution in the microstructure.  X-ray diffraction was used to 
identify the crystalline phases present and qualitatively determine the phase fraction. In the 
determination of CaO or CaCO3 phases, XRD and SEM were the main methods used. 
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5.2.1 XRD  
In XRD analysis, the phases on the as-sintered pellet surfaces and machined cross-section 
surfaces were determined. Additionally, the pellet was ground into powder and analyzed. 
As the HA main characterize peak (221) is at the range of 30 to 33° for 2θ, and the 
CaCO3 main peak is at 33.909° as seen in Figure 5.1(b).The XRD scanning 2θ range was 20° to 
80°. 
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Figure 5.1 X-ray diffraction standard pattern for (A) HA, (B) CaCO3 
 
A 
B 
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5.2.2 SEM Observation 
Scanning electron microscopy analysis was done on the sintered surface of the infiltrated sample 
pellets and the uninfiltrated control pellets. In order to compare the differences in microstructure 
and the dissolution behavior with/without infiltration, the samples were impregnated with a low 
viscosity resin and ground to a planar surface by EcoMet 250 Grinder-Polisher (Buehler, Lake 
Bluff, IL). In this procedure, both external surface and cross-section of one sample should be 
mounted in resin. The samples were grounded with 45 μm and 30 μm diamonds in water loaded 
with 18 lbs. at 60 RPM.  Then, the samples were pre-polished with 15 μm diamond with 
polishing oil AT 17 lbs. at 70 RPM. Finally, the polishing was completed with 6 μm diamond 
and 1 μm diamond with oil loading 16 lbs. at 50 RPM. 
After polishing the samples were coated with palladium using a sputter coater and 
examined in a Phillips XL30 scanning electron microscope. Besides secondary electron images, 
backscattered images were also taken for the second phase detection (CaO or CaCO3) by 
contrast. In order to assist the Ca-rich phase detection, EDS was combined with back-scattered 
imaging. As CaO and CaCO3 has no phosphorous, EDS result confirmed the presence of a high 
calcium phase. 
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5.3 SOLUBILITY EXPERIMENTS 
5.3.1 Static Solubility Testing on Pellets 
Pressed hydroxyapatite pellets were infiltrated with 1M Ca2+ solution as described above. The 
negative control group was processed similarly but not infiltrated.  All the samples were 
impregnated with a low viscosity resin and ground to a planar surface. After grinding with 45 μm 
and 30 μm diamonds in water the samples were pre-polished with 15 μm diamonds and 6 μm 
diamonds with polishing oil and finally with 1 μm diamonds in polishing oil.  
After polishing the pellets were removed from the mounting resin and placed in sealed 
tube containing 50 ml Tris-bufffer Saline (TBS).  At each time point, listed in Table 1, two 
pellets were removed from the TBS, one for the infiltrated group and the other from negative 
control group.   
Table 1. Static solubility experiment time point 
Time 
pellet 
0.5 hr 1 hr 12hrs 24 hrs 72hrs 1 week 2 week 4 week 
HA pellet         
1 M infiltrated 
HA pellet 
        
2M infiltrated 
HA pellet 
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After immersion the pellets were dried with Kimtech Wipes and stored in a desiccator 
while the Ca2+ concentration in the TBS was measured using Ca2+ probe (Roche, detection limit 
0.001mmol/L). The exposed polished surfaces were then examined in SEM. 
 
5.3.2 Static Solubility Testing on Scaffolds 
Hydroxyapatite scaffolds were infiltrated with 2M Ca2+ solution as described above. The 
negative control group was processed similarly but not infiltrated.  All the samples were 
prepared as 0.0300 (+/- 0.001) g / sample and placed in sealed tube containing 1.5 ml Tris-buffer 
Saline (TBS).  At each time point, listed in Table 2, two scaffolds were removed from the TBS, 
one for the infiltrated group and the other from negative control group.   
Table 2. Static solubility experiment time point for hydroxyapatite scaffolds 
Time 
scaffold 
0.5 hr 1 hr 12 hrs 24 hrs 72hrs 1 week 2 week 4 week 
HA scaffold         
2M infiltrated 
HA scaffold 
        
 
After the scaffolds were dried with Kimtech Wiper they were stored in a dessicator while 
the Ca2+ concentration in the TBS was measured using a Ca2+ probe (Fisher Scientific™ 
Accumet™ Polymer Membrane Combination ISEs, Pittsburgh, USA, detection limit 0.001ppm) 
The scaffolds were then examined in SEM. 
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5.4 BIOCOMPATIBILITY EXPERIMENT 
5.4.1 Endothelial Cell Biocompatibility Testing 
For the endothelial cell biocompatibility testing, the cell type used was Human Umbilical Vein 
Endothelial cells, (HUVEC) passage 5. Hydroxyapatite foam was used for a control condition 
and hydroxyapatite foam, infiltrated with 2M Ca2+, was tested for biocompatibility. 
In this experiment, three parallel repeats are applied for biological variability. In each 
repeat, there were three controls as listed in Table 3. 
Table 3. Endothelial cell biocompatibility experiment controls and time points in each repeat 
Time 
 
variables 
5 days 15 days 42 days 
Medium + Cells    
Medium+ cells + 
HA 
   
Medium+ cells + 
Infiltrated HA 
(2M) 
   
 
In Table 3, the Medium with cells condition was used as a positive control and there were 
three time point for all conditions. In each condition, three wells were applied for the different 
testing conditions. 
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Also, another two controls, medium and medium with HA foam, were designed for 
negative controls. In those two controls, there was no need to repeat three times because there 
was no cells and the only time point was 42 days. For these two conditions there were also three 
wells. 
In the experiment process, the endothelial cell-line was taken from freezer and cultured. 
Meanwhile, scaffolds were put into labeled plates and sterilized with ethylene oxide. The cell 
culture medium formulation is given in Table 4. The Ca concentration in medium is 0.700 (+/-
0.005) mmol/L. 
Table 4. HUVECs Medium formulation 
Supplement Amount Supplier 
Heparin 0.1 mg/mL Sigma Aldrich 
Endothelial cell 
growth supplement 
0.05 mg/mL Sigma Aldrich 
Fetal bovine serum 10% PAA 
Anti-anti 1% Invitrogen 
F12-K Basal medium Invitrogen 
 
Cells were suspended in cell culture medium and added at a concentration of 2E4/ml. In 
each well, 0.5 ml EC suspension was added to the center of scaffold or well bottom with 1E4 
cells in each well. After plating, the ECs were cultured in an incubator at 37°C and 5% CO2 for 
42 days. The cell culture medium was replaced every 2-3 days to replenish nutrients and remove 
waste products.  Aspirated medium was saved for future analysis. At each time point (5, 15, and 
42 days), wells were harvested for gene expression. 
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In the endothelial cell biocompatibility experiment, three characterization methods were 
used to analyze the cell cultures. The first was glucose and lactate measurement, to determine the 
cell activity to give some indication of relative cell numbers.  When the medium was changed at 
each time schedule, some was saved for future analyses while some it was used to measure 
glucose, lactate and Ca2+ ion concentrations. 
RNA was extracted from the cell lysate using a kit from Qiagen. Reverse transcription 
polymerase chain reaction (PCR) was subsequently performed on the RNA, resulting in c-DNA 
samples. Real-time PCR (RT-PCR) was used to examine the cell types in the culture through 
gene expression. 25 ng of c-DNA from each sample was used and tagged with fluorescent 
TaqMan probes (Invitrogen), which bind to the specific gene sequences of interest. The 
following list shows the 5 markers used and their significance: 
1. β-actin – one of six actin isoforms found in all human cells. This is used as a control 
gene to normalize the gene expression data. 
2. CD 31 and CD144 – both of the markers are the endothelial progenitor markers which 
will participate in vascularization 
3. von Willebrand Factor (vWF) – a marker of mature vascular endothelial cell 
4. Antigen KI67 – a marker for cells in the proliferation stage 
For the 3 repeats using the cell-line, prior to RNA isolation, the lysates were passed 
through a column to isolate genomic DNA from the samples. This was then quantified using a 
Qubit fluorometer (Invitrogen) and a double stranded-DNA assay kit and compared to the DNA 
–cell amount standard curve, which was draw by measuring DNA amount of different cell 
amounts. 
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5.4.2 Hematopoietic Stem Cells / Osteoblasts Co-Culture Biocompatibility Testing 
In the hematopoietic stem cells/ osteoblasts co-culture testing, the HSCs and osteoblasts 
were mixed in the ratio of 9:1. This ratio is about an order of magnitude higher than the fraction 
of HSCs in the human bone marrow cell fraction. The HSCs are primary cells from healthy 
donors and the osteoblasts are the Saos-2 cell line. Hydroxyapatite foam was used as the control 
condition and hydroxyapatite foam conditions, infiltrated with 1M and 2M Ca2+, were tested for 
biocompatibility. 
In this experiment, three parallel repeats are applied to account for biological variability 
between different HSC donors. In each repeat, there were three controls as listed in Table 5. 
Table 5. Hematopoietic stem cells / osteoblasts co-culture experiment controls and time points in each 
repeat. 
Time 
variables 
5 days 14 days 28 days 42 days 
Medium + Cells     
Medium+ cells + HA     
Medium+ cells + 
Infiltrated HA (1M) 
 
 
  
Medium+ cells + 
Infiltrated HA (2M) 
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In Table.5, the Medium + Cells condition was used as a positive control and there were 
four time point for all conditions. In each condition, three wells were applied for the different 
testing conditions. 
Also, another two controls, Medium and Medium with HA foam, were designed for 
negative controls. In those two controls, there was no need to repeat three times because there 
was no cells and the only time point was 42 days. For these two conditions there were also three 
wells. 
In the experiment process, the HSCs were mixed with pre-cultured osteoblasts as soon as 
delivered with fixed ratio of 9:1. Meanwhile, scaffolds were put into labeled plates and sterilized 
with ethylene oxide. The cell culture medium formulation is given in Table 6. 
Table 6. HSCs Medium formulation 
Supplement Amount Supplier 
Human-specific 
Mesencult 
supplement 
0.01 ml/mL 
StemCell 
Technologies 
AB Human serum 5% Sigma-Aldrich 
Anti-anti 1% Invitrogen 
Human-specific 
Mesencult Medium 
Basal medium 
StemCell 
Technologies 
 
Cells were suspended in cell culture medium and seeded as 5000 cells/ cm2 into the 
culture plates. In each well, 4 ml cell suspension was added to the center of scaffold or well 
bottom. After plating, the cells were cultured in an incubator at 37 °C and 5% CO2 for 42 days. 
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The cell culture medium was replaced every 2-3 days to replenish nutrients and remove waste 
products.  Aspirated medium was saved for future analysis. At each time point (5, 14, 28 and 42 
days), wells were harvested for fluorescence activated cell sorting (FACS) and the CFU assay. 
In the HSC/osteoblasts cell biocompatibility experiment, three characterization methods 
were used to analyze the cell cultures. The first was glucose and lactate measurement, to 
determine the cell activity and gives some indication of relative cell numbers.  When the medium 
was changed at each time point, some was saved for future analyses while some it was used to 
measure glucose, lactate and Ca2+ ion concentrations. 
Fluorescence Activated cell Sorting (FACS) was applied to the experiment for the cell 
type and to study differentiation. In FACs, cells could be identified and counted by the special 
protein expression on the cell membrane. Based upon the specific light scattering and fluorescent 
characteristics of each cell, the cells could be sorted and separated individually157.  
For surface marker staining, cells were incubated with fluorochrome conjugated 
antibodies: FITC-Linage cocktail (Lin), PerCPCy-CD34, BV421-CD31, PE-CD235a, APC-H7-
CD45, AF700-CD38 (all Becton Dickinson). Compensation beads (Becton Dickinson) were used 
to compensate potential spectral fluorochrome overlap when cells were analyzed with a FACS 
Aria II. In data analysis used FlowJo software version 9.5.2 (Tree Star, Ashland, OR), a forward 
versus side scatter gate was applied to excluded cell debris and cell doublets 
The Colony Forming Unit Assay (CFU) is a method to investigate the potential of 
hematopoietic progenitors to form colonies of differentiated cells in the hematopoietic lineage. 
Fresh mixed cells and the co-cultured cells from the four scaffold conditions were assayed using 
5000 cells, and the cells were cultured in conventional Petri dish with counting after 14 days of 
culture by phase microscopy (Zeiss Invertoskop C, Carl Zeiss, Jena, Germany). A complete 
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MethoCult methylcellulose-based assay was used according to manufacturer’s instructions 
(StemCell Technologies). Four different types of colonies were identified and their frequencies 
compared to expected numbers as given by the manufacturer: CFU-E (Colony Forming Unit – 
Erythrocyte), BFU-E (Burst Forming Unit – Erythrocyte), CFU-GM (Colony Forming Unit – 
Granulocytes, Macrophage), CFU-GEMM (Colony Forming Unit – Granulocyte, Erythrocyte, 
Macrophage, Megakaryocyte)158. 
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6.0  RESULTS AND DISCUSSION 
6.1 INFILTRATION PROCESSING 
As described in the first objective, a soluble Ca-rich phase should be introduced into HA 
ceramic. With this second phase, the HA degradation rate could be increased with higher 
concentration of Ca2+ released into the medium. Additionally, the soluble phase could be 
distributed in the HA ceramic so as to release Ca2+ over a 42 days period. 
6.1.1 Effect of the Infiltration on the Phase Distribution in Pellets 
Figure 6.1 shows the x-ray diffraction patterns for the infiltrated pellets. HA and CaCO3 were 
present in the infiltrated pellet surface. The CaCO3 standard peaks were labeled with stars in 
Figure6.1. It is apparent that HA is the main phase found in the pellet surface.  Fig 6.1 (a), shows 
the three main HA peaks were shown at 37.07º, 37.56 º and 38.42 º as in the standard HA pattern. 
Also, Figure 6.1 also shows minor peaks at 33.91 º and 42.12 º, which belong to CaCO3. The 
CaCO3 was formed after sintering by the reaction of the CaO second phase with moist air 
containing CO2 in ambient conditions.   
With the x-ray diffraction result, the quantity of the CaCO3 was calculated using equation 
6.1: 
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        Eqn 6.1 
The quantity of the CaCO3 in the infiltrated foam was calculated to be approximately 3%, 
which is quite a small amount when compared with the HA phase. 
 
Figure 6.1 X-ray diffraction patterns of infiltrate HA pellet surface (* stands for CaCO3 peak, green line 
stands for HA main peak) 
Although the peak intensity of CaCO3 in the X-ray diffraction result was quite small, the 
existence of the peak proved that the infiltration process did introduce a Ca-rich phase into HA. 
Also, the new phase is CaCO3, which has a much higher solubility than HA111and is therefore 
expected to release calcium into the media. 
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6.1.2 Microstructural Analysis of Polished Surfaces on Pellets 
Microstructural analysis of surfaces and the sections through the infiltrated HA pellets showed 
the second phase distribution derived from the infiltration process.  As the Ca-rich phase is 
soluble with water, when polished with water, pits and defects appeared on the polished surface. 
In the Figure 6.2, polished surfaces of the infiltrated HA pellets shows pits on the surface while 
the pure HA pellets are still quite smooth and flat. Figure 6.2(A) is the HA pellet surface and 
there are no pits. Figure 6.2(B), (C), and (D), have defects which are created by dissolution of the 
CaCO3 during the polishing process. Also, the pellets infiltrated with higher calcium nitrate 
concentration did not show significant difference in the population of defects on the pellet 
surface.. In the infiltration process, the solution was introduced into the HA ceramic from the 
external surface and would be expected to create a gradient in the second phase which would 
diminish from the surface to the interior. 
Even though the concentration of Ca2+ solution was increased, the external surfaces of the 
infiltrated HA pellets showed approximately the same amount of Ca-rich phase formation. This 
is probably due to concentration of the nitrate by precipitation on the surface during drying.  This 
would lead to similar amounts of CaCO3 on the external surface since the nitrate would exceed 
its solubility limit at this location irrespective of the calcium nitrate concentration in the 
infiltrate. 
The defects formed by dissolution of the CaCO3 are much larger than the second phase 
particles observed in SEM as shown in Figure 6.3(A) and (B., Therefore the dissolution of the 
CaCO3 must also be removing adjacent grains of hydroxyapatite. Also, the EDS result of Figure 
6.3 (C) show that the Ca/P is 2.04, which is much larger than 1.67, the HA standard Ca/ P ratio.  
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This is thought to be due to the fact that most of the x-rays originate from the CaCO3 particle but 
some also originate from the surrounding HA grains. 
 
Figure 6.2. SEM for the surface of pellets. A) HA pellet surface; B) 0.5M calcium nitrate infiltrated HA 
pellet surface; C) 1M calcium nitrate infiltrated HA pellet surface; D) 2M calcium nitrate infiltrated HA pellet 
surface 
A B 
C D 
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Figure 6.3. Polished surface of Ca2+ solution infiltrated HA pellet (A) BSE, (B) SEM, and (C) EDS 
In Figure 6.4, shows the morphology at defects at higher magnification.  The defects had 
faceted boundaries suggesting grains had been removed by the dissolution process, as Figure 6.4 
(B), (C), and (D) demonstrates.  Therefore the shape and size of the defects caused by dissolution 
result not only from the CaCO3 dissolution, but also from the removal of the HA grains that are 
coordinated to the CaCO3 particles. It is thought that, CaCO3 formation from CaO on exposure to 
water or moist air causes a volume change that cracks the surrounding material and allows 
coordinating HA grains to be removed. 
  
A B 
C 
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Figure 6.4. SEM on pellet surfaces: A) HA pellet surface; B) 0.5M calcium nitrate infiltrated HA pellet surface; C) 
1M calcium nitrate infiltrated HA pellet surface; D) 2M calcium nitrate infiltrated HA pellet surface 
Also, micrographs from the thermal-etched samples after polishing supported this 
conclusion. In Figure 6.5, the pellet was polished and then thermal-etched to show grain 
boundaries. According to this SEM picture, the defects are larger than a single HA grain and 
have a similar faceted shape as the grains. When back-scattered electron imaging was applied to 
more clearly observe the second phase, as in Figure 6.6, it is found that the size of the CaCO3 
particles was much smaller than HA grains observed in in Figure 6.5.  In the Fig 6.6(A), the 
small white dots are calcium rich and thought to be CaO or CaCO3 phase,  
A B 
C D 
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Figure 6.5. Thermal-etched infiltrated HA pellet 
 
Figure 6.6. Polished surface of infiltrated HA pellet (a) BSE, (B) SEM 
The CaCO3 was dispersed throughout the polished sample section but is concentrated 
towards the external surface. In other words, the CaCO3 distribution is heterogeneous but is 
present throughout the bulk of the ceramic. 
 
 
A B 
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Figure 6.7. A) section of infiltrated HA pellets and B) section of HA pelltes 
Figure 6.7, shows how the defects are dispersed throughout the section of the pellet when 
a cross-section is exposed to moisture during polishing, this suggests that the CaO second phase, 
is dispersed throughout the pellet. The results suggest that infiltration is a valid processing 
method for manufacture of these new biphasic ceramic containing a soluble second phases. 
However, there is a gradient in the CaO second phase fraction which decreases from the external 
surface towards the interior as previously observed by Lange et al in alumina infiltrated with 
zirconia ceramics164. 
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Figure 6.8. The defect size distribution on the section of infiltrated HA pellets in Figure 6.7 
At the external surface, the defect area fraction was 29.6 (+/- 3) %. After moving the fields of 
measurement into the interior, at the location of 100 µm-away from external surface, the defect 
area fraction decreased to 20.3 (+/-3) %, and the measured pore size distribution shifted to 
smaller sizes.  Figure 6.8 shows that adjacent to the pellet surface the pit size distribution was 
multi modal with modes at approximately 34 µm (14 HA grain diameters) and 22 µm (9 HA 
grain diameters).  At the location 100 µm from the surface the pore size distribution was still 
multimodal with the largest mode in pit size distribution ranging from 25.2-27.2 µm (10.5-11.5 
HA grain diameters) with a secondary mode between 13.2 and 15.2 µm (5.5-6.5 HA grain 
diameters). Therefore the change in the defect area fraction reflects the expected decrease in the 
phase fraction of CaO with distance from the exterior surface of the sample in infiltrated samples 
but it is also interesting to observe the decrease in the size of the pits suggest that the spatial 
clusters of CaO that result in pits on transformation to CaCO3 are also smaller further into the 
interior of the samples. The decrease of the size corresponding to the defect modes continue on 
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moving 150µm-away from external surface, but the changes are small and not thought to be 
significant. The defect area fraction at a distance of 150 µm was 19.2 (+/-3) %, and the first 
mode of the pit size distribution was, 12.8-14.8 µm and the second mode of pit size distribution 
had decreased to 17.2-18.8 µm. There appears to be no further change in pit fraction and pit size 
at larger distances from the external surface of the sample. Figure 6.9 (B), shows no faceted 
pitting defects on the section of the control HA sample. 
Also, in order to confirm the defects are produced by water attacks, HA pellets and 
infiltrated pellets where sonicated with water and also with isopropanol.  
 
Figure 6.9. Polished HA pellet surface (A) with propanol, (B) with water 
Figure 6.9, shows no significant difference between single-phase HA pellets that were 
ultra-sonicated with water or alcohol. Both of the pellets had smooth and flat surfaces without 
any defects, though some pores were present as shown in figure 6.9(A). However, Figure 6.10 
shows that for the Ca2+ solution infiltrated pellets, ultra-sonicated with alcohol the defects were 
not present.  When sonicated with water, the defects were throughout the sample as before.  
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Figure 6.10. Polished surface of infiltrated HA pellet (A) with isopropanol, (B) with water 
As the XRD results suggest that the CaCO3 is present in very small volume fractions (3 
% to 5%). However, the defects produced on the surfaces of infiltrated pellets polished in water 
accounted for a much larger fraction of the surface. Again, this is consistent with HA grains 
being removed from the surface during transformation of CaO to CaCO3 and the dissolution of 
the CaCO3.In summary, the CaO content in the ceramic body caused fragmentation of HA when 
the CaCO3 is formed and subsequently dissolved.  
6.1.3 Effect of the CaCO3 Phase on Dissolution and Damage Accumulation on Polished 
Surface of Pellets 
As mentioned above, the infiltrated ceramic should be capable of releasing Ca2+ into the medium 
in the long term culture of HSCs. Also, in the HSCs culturing, Ca2+ should release at a steady 
rate through the culture period. Therefore the time dependent dissolution and damage 
accumulation of the biphasic CaP ceramic created using infiltration of HA must be studied.  Two 
CaCO3 fractions were created as pellets by varying the concentration of the infiltrant solution (1 
mol/L and 2 mol/L Ca(NO3)2·6H2Osolution). As described previously, the pure HA pellet was a 
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negative control. The solubility of the pellets was tested in static condition, as described in the 
experimental procedures section. 
The experiment shows significant differences in dissolution between the negative control 
and the infiltrated pellets. As shown in Figure 6.11, the infiltrated pellets released more Ca2+ ions 
in the saline than the HA pellets, especially for the 1mol% samples at 28 days. Interestingly, the 
calcium released decreased more for 2 mol/L infiltrated HA pellets at 28 days, possibly due to 
precipitation of calcium phosphate. The range of the Ca probe in Cobas 211 is 0.04 to 40 
mmol/L. 
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Figure 6.11. Ca2+ ion concentrations in the Tris-buffered saline were plotted as a function of time for static 
experiment on pellet samples. 
The pellets used for the dissolution experiments were also observed in SEM on polished 
surfaces parallel to the sintered surface and as close to the sintered surface as possible. At the 
first two time points, 0.5 and 1 hour, there was no significant difference between the damage on 
the surface of the pellets at these two time points for the same condition. There were defects on 
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the surface of the infiltrated pellets, while there are no defects on the HA pellets at 0.5 and 1 
hour samples. 
However, the defects (Figure 6.12) in the 2M infiltrated pellets were deeper than the 
defects on 1M infiltrated pellets. 
 
Figure 6.12. 0.5 hours microscopy for pellet surfaces (a) HA pellet, (b) 1M Ca2+ solution infiltrated HA pellet, (c) 
2M Ca2+ solution infiltrated HA pellet 
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Figure 6.13. 1 hour microscopy for pellet surfaces (a) HA pellet, (B) 1M Ca2+ solution infiltrated HA 
pellet, (c) 2M Ca2+ solution infiltrated HA pellet 
After 1 day, there were still no pits on the HA pellet surface. In the two infiltrated 
conditions, the defects grew deeper as time pass by and HA grains were removed layer by layer. 
This must involve a fragmentation process where exposure of CaO to moisture causes 
transformation to CaCO3 and the volume expansion cracks HA grain boundaries and allows the 
removal of adjacent HA grains.  This exposes new CaO particles underneath and releases more 
Ca2+ ions into solution by dissolution of the CaCO3.  At Day 3, the defects began to appear on 
HA pellet surface but the resulting defects were much smaller than those on the -infiltrated 
pellets. The depth of the defects continued increasing for the -infiltrated pellets and some of the 
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defects began to connect with each other on the surface of 2M infiltrated pellet. The defects may 
have coalesced by removing the HA grains between them during fragmentation. 
 
Figure 6.14. 1 day microscopy for pellet surfaces (a) HA pellet, (B) 1M Ca2+ solution infiltrated HA pellet, (c) 2M 
Ca2+ solution infiltrated HA pellet 
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Figure 6.15. 3 day microscopy for pellet surfaces (a) HA pellet, (B) 1M Ca2+ solution infiltrated HA pellet, (c) 2M 
Ca 2+ solution infiltrated HA pellet 
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Figure 6.16. 7 day microscopy for pellet surfaces (a) HA pellet, (B) 1M Ca2+ solution infiltrated HA pellet, (c) 2M 
Ca2+ solution infiltrated HA pellet 
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Figure 6.17. 14 day microscopy for pellet surfaces (a) HA pellet, (B) 1M Ca2+ solution infiltrated HA pellet, (c) 
2M Ca2+ solution infiltrated HA pellet 
The same trend in deepening of the defects appeared to continue at the next three time-
points, Day7, Day 14 and Day 28, as seen in Figure 6.16, 6.17 and 6.18. More and more HA 
grains were removed on the infiltrated pellets at the preexisting defect positions while defects 
continued to coalesce. Comparing the two Ca solution infiltrated pellet conditions, defects on 2M 
infiltrated pellets were more severe than the defects on 1M solution infiltrated pellets. The center 
of defects on the 1M solution infiltrated pellet was removed and created a quiet deep pit, as seen 
in the Figure 6.18(B). Figure 6.18, shows three large defects and the solid between them has 
been mostly removed. The three defects are connecting with each other, and the boundary 
between two of them had already been removed. 
C 
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From the microscopy, it is found that the degradation of the ceramic is enhanced due to 
the presence of the second phase, which results not only in removal of a soluble phase but also in 
the fragmentation of adjacent HA. 
 
Figure 6.18. 28 day microscopy for pellet surfaces (a) HA pellet, (B) 1M Ca2+ solution infiltrated HA 
pellet, (c) 2M Ca2+ solution infiltrated HA pellet 
Figure 6.18(A) shows that the pits in the HA were much smaller than those on the 
infiltrated samples. The size distribution of the pits was measured on the polished surfaces close 
to the sintered surface using image analysis. Significant differences were observed over the 4 
weeks in saline.  The size distribution of the defects on the pure HA pellets changed little by 
comparison with the distributions found on the infiltrated samples. For the HA control condition, 
the pits did not appear until the third day. Then, a size distribution with a single mode of 
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equivalent sphere size 1- 1.4 µm was found .From Day 3 to Week 4 the pit area fraction on the 
HA samples only grew from 2.3 (+/-0.5)% to 2.4 (+/-0.5)%. Figure 6.19 shows pit distribution 
on HA pellets for 4 different time points over a 4 week period.  The size distribution is an order 
of magnitude smaller in size (0.8 µm to 3.6 µm) and does not have the multimodal character of 
the pits on the surface of the infiltrated pellets. There is some evidence that the mode does 
increase slightly during 4 weeks of soaking. But they remain smaller than the HA grain size 
measured on the etched surface (Figure 6.19).  
 
Figure 6.19. The defect distribution on HA pellet surface 
For the 1M infiltrated pellets, the defect area fraction increased significantly from 22.6% 
after 1 hour and 23.1 % 3 hours, to 24.2% after 1 week and finally to 29.4% after 4 weeks. 
Figure 6.20 shows the distributions of pit size for the 1M infiltrated HA pellets.  This figure 
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shows distributions for 4 time points from 1 hour to 4 weeks. Clearly, the distributions are 
multimodal and new modes appear at larger pore sizes at the longer soak times.  The distinct 
multimodal distributions are thought to be due to the effect of the HA grain size on the pit 
coarsening mechanism. 
 
Figure 6.20. The defect distribution on 1M infiltrated HA pellets 
Compared with 1M infiltrated pellets; the 2M infiltrated pellets showed the same trend in 
defect area fraction during the solubility experiment. The defect area fraction increased 
significantly from 18.8% after 1 hour and 20.1 % at 3 hours, to 24.2% after 1 week and finally to 
30.1 % after 4 weeks. Figure 6.21 shows the distributions of defect size for the 2M infiltrated HA 
pellets.  This figure shows distributions for 4 time points from 1 hour to 4 weeks. Comparing 
with 1M infiltrated HA pellets, the 2M infiltrated HA pellets had higher percentages of defects in 
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the size range from 6 to 18µm at short-term solubility test, 1hour and 3days. However, in the 
long term, 2M infiltrated pellets and 1M infiltrated pellets had similar multimodal distributions. 
 
Figure 6.21. The defect distribution on 2M infiltrated HA pellets 
As the soak time increased from 1 hour to 4 weeks the major mode in defect size grew 
from 14 (1M infiltrated HA) or 18(2M infiltrated HA) µm to 26 µm and other modes appeared at 
larger equivalent sphere diameters after 4 weeks. This is thought to be a result of the degradation 
mechanism in which CaO grains in contact with saline on the surface transformed to CaCO3 and 
the resulting volume expansion caused cracking that removed adjacent HA grains and so the 
coarsening of the pits occurred in a discontinuous fashion by fragmentation events that removed 
whole HA grains or small groups of HA grains from preexisting defects and thereby exposed 
subsurface CaO grains to moisture which consequently transformed and led to other 
fragmentation events that deepened the defects and released more calcium ions..  
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The number of defects per unit area was also determined from the thresholded images. 
Figure 6.22 shows the plot of the number of defects/ unit area on the polished surface for the 
different degradation times. The numbers of pits per unit area on infiltrated HA pellets does not 
change significantly after 1 hour and for pure HA after 3 hours the number of pits per unit area is 
relatively constant. Hence, new pit formation does not seem to be significant after the very short 
soak times. The number of pits per unit area on the infiltrated samples is also higher than for the 
HA control samples. 
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Figure 6.22. Number of defects/ unit area on the pellet surface 
In summary, the area fraction of pits, the pit size and the depth of the pits increased on 
the surface of infiltrated pellets over 28 days due to the presence of CaO which not only 
dissolves rapidly but also transforms to CaCO3.  The volume increase on the transformation 
causes cracking of the HA grain boundaries and the enlargement of adjacent pits by the removal 
of HA grains by fragmentation. These grains are not thought to contribute much to the calcium 
content of the media but the exposure of new CaO grains by the fragmentation process leads to 
continued release of calcium into the media. This mechanism is reflected in the evolution of the 
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size distribution of the defects, particularly the appearance of new modes at larger defect sizes. 
Interestingly there is no further increase in the number of defects per unit area of the surface after 
the first hour and so the number of defects is mainly controlled by the initial transformation and 
dissolution of CaO grains on the surface. As the defects enlarge by fragmentation they must 
continue to produce new small satellite defect sections that intersect with the polished surface 
and then are merged with the adjacent larger pit at longer times.  This would result in no 
significant change in the number of pits per unit area on the polished surfaces. 
6.1.4 Effect of the Infiltration on the Phase Distribution of Foams 
Figure 6.23 shows the x-ray diffraction patterns for the infiltrated foams. HA and CaCO3 were 
present in the ground foam, which in the ground state represents the entire solid volume in the 
foam. The CaCO3 standard peaks were labeled with stars in Figure 6.23 (B). It is apparent that 
HA is the main phase found in the ground powders.  Fig 6.23 (A), shows the three main HA 
peaks were shown at 37.07º, 37.56 º and 38.42 º as in the standard HA pattern. Also, Figure 6.23 
(B) also shows minor peaks at 33.91 º and 42.12 º, which belong to CaCO3. The CaCO3 was 
formed after grinding by the reaction of the CaO second phase should with CO2 in ambient 
conditions.  The quantity of the CaCO3 in the infiltrated foam was calculated to be approximately 
3%, which like the pellets is quite a small amount when compared with the HA phase. 
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Figure 6.23 X-ray diffraction patterns of (A) (B) ground foam 
6.1.5 Infiltration of HA foams 
In the pellet system, the CaO- HA biphasic system released Ca2+ into saline over 4 weeks and 
resulted in surface defects by dissolution and fragmentation. If these materials are to be used to 
culture HSC s in bioreactors, highly porous scaffolds are required. The dissolution behavior of 
the biphasic CaP ceramic should therefore be tested in this high porosity system, which has a 
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much higher surface area.  As described previously, the pure HA scaffolds are used in the 
experiment as a negative control, with an infiltrated group made with 2mol/L Ca(NO3)2 solution. 
By Micro-CT (Micro Photonics Inc., Allentown, PA), the open porosity of the scaffolds was 
measured at approximately 87% with total porosity 90% showing that the majority of the 
porosity is open. The solubility of the scaffolds was tested in static condition, as described in the 
experimental procedures section. 
The experiment shows significant differences in dissolution between the negative control 
and the Ca2+ solution infiltrated scaffolds. Figure 6.24 shows, the Ca2+ solution infiltrated 
scaffolds released more Ca2+ ions in the saline than the HA scaffolds. At 0.5 hour, the Ca 
concentration in the 2M infiltrated HA scaffold condition is about 0.3mmol/L while in the HA 
scaffold condition it is smaller than 0.04 mmol/L.  The Ca concentrations in the saline did not 
increase significantly until day 3.  There is a peak in Ca2+ in the saline at 72 hours for the 2M 
infiltrated scaffolds with Ca concentration at approximate1.5 mmol/L. From 1 week to 4 weeks, 
the Ca2+ concentrations in the 2M infiltrated HA scaffold condition increased but not 
significantly. For the HA scaffold condition, the Ca concentration increased to 0.1 mmol/L s at 1 
week. During the next two time points, the Ca concentration plateaued in the Figure 6.24. 
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Figure 6.24 Ca2+ ion concentration in the tris-buffered saline plotted as a function of time for static 
experiment. 
In order to explain the trend in Ca release, the microstructure was observed by SEM. At 
the first two time points, 0.5 and 1 hour, There were defects on the surface of the infiltrated 
scaffold, while there is no defect observed on the HA scaffolds at these same time points. 
Interestingly, the defects (Figure 6.25) in the 2M infiltrated pellets were deeper than the defects 
on 2M Ca solution infiltrated pellets. 
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Figure 6.25 0.5 hour exposure for scaffold surfaces (A) HA, (B) 2M Ca2+ solution infiltrated HA 
 
Figure 6.26 1 hour exposure for scaffold surfaces (A) HA, (B) 2M Ca2+ solution infiltrated HA 
 
Figure 6.27 1 day exposure for scaffold surfaces (A) HA, (B) 2M Ca2+ solution infiltrated HA 
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Figure 6.26 and Figure 6.27 shows there are no defects on the HA scaffolds surfaces, 
while the defects on the 2M infiltrated HA scaffolds surfaces became deeper and larger. From 1 
day to 3 days, the defects began to connect with each other and more material has been removed. 
In consequence, the Ca2+ concentration in the saline increased significantly for the 2M n 
infiltrated HA in Figure 6.28. 
 
Figure 6.28 3 days exposure for scaffold surfaces (A) HA, (B) 2M Ca2+ solution infiltrated HA 
 
Figure 6.29 7 days exposure for scaffold surfaces (A) HA, (B) 2M Ca2+ solution infiltrated HA 
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Figure 6.30 14 days exposure for scaffold surfaces (A) HA, (B) 2M Ca2+ solution infiltrated HA 
 
Figure 6.31 28 days exposure for scaffold surfaces (A) HA, (B) 2M Ca2+ solution infiltrated HA 
From 7 days to 28 days, some defects were observed on the surfaces of the infiltrated HA 
scaffolds and became more numerous with increased soaking time. On the 2M infiltrated HA 
scaffolds, the defects became larger and made the scaffolds more fragile.  Compared with the 
defects on HA scaffolds, the defects on the 2M infiltrated HA scaffolds showed many more 
defects (Figure 6.28(B)). In the Figure 6.31 (B), a piece of the scaffold was removed by the 
fragmentation.  The increase in structural damage correlated with the enhanced Ca2+ 
concentration in the saline after 28 days for the 2M infiltrated HA scaffold. 
A B 
A B 
 85 
In summary, the Ca-rich phase enhanced the Ca2+ ion concentration in the saline to much 
higher levels compared with the pellets and also resulted in defects that could be clearly 
observed on the scaffold surface.  
6.2 HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS CULTURING  
The first intended cell source for this study was a human umbilical vein endothelial cell line 
(HUVEC) which is commonly used as cell type that contains a large fraction of endothelial 
progenitors but no HSCs. Three biological repeats were applied to test the biocompatibility of 
the biphasic materials produced in this study. The endothelial cells are the cells that form the 
vessels in the human body and will be extremely important to the process of vascularization 
during tissue formation in vitro cell culture. 
6.2.1 Genomic DNA data and Medium Analysis during Culture 
Three parallel repeats were studied for the HUVECs proliferation. In order to study the cell 
proliferation, genomic DNA was taken from harvested cells at each culture time point in all three 
repeats. The three different conditions used where:  (A) the HUVECs cultured without any 
scaffold as a negative control, (B) the HUVECs cultured with HA scaffold, and (C) the HUVECs 
cultured with 2M Ca solution infiltrated HA scaffold.  This will allow for the study of the effect 
of the scaffold and the effect of calcium concentration on the fate of the HUVEC cells. The cell 
number was calculated by measuring the total amount of DNA in each sample and comparing 
this number to the DNA from a known amount of cells. 
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As it is shown in the Figure 6.32, in the first 15 days, the cell numbers increased in all 
three conditions from 1E4 cells/well initially. From day 5 to day 15, there were changes in the 
cell numbers for three conditions.  The increase for the no-scaffold condition was significant as 
well as for the infiltrated scaffold over the first 15 days in these samples in comparison there was 
a decrease in total cell number for the HA scaffold between day 5 and day 15. This general 
proliferation might be due to the cells becoming attached to the surface of culture wells or the 
scaffold and starting to proliferate. However, after 42 days, the number of cells significantly 
decreased in all conditions, which is not surprising for static culture where the cells do not 
proliferate after this length of time without passaging due to confluence and consequent cell 
depth.  At all three time-points the results showed that the no-scaffold condition had the largest 
cell number. This might be because of the surface morphology difference between the material 
of the culture well and the scaffold. HUVECs are more likely to attach to the polystyrene surface 
of culture wells than to the ceramic surface of the HA scaffold. As mentioned previously, the 
decrease in the number of cells between day 15 and day 42 samples is expected if the cells are 
not proliferating.  The life expectancy for HUVECs as 50 to 60 population doublings (population 
doublings refers to the times one cell is able to divide into two, and has nothing to do with the 
number of passages)159. With a certain life-time period, a cell cycle time of 19.9+/-2.73 h for 
early passage HUVECs compared with 23.3+/-1.32 h for late passage cells, the total life-time of 
most HUVECs is 30 to 38 days. The time period is shorter compared to our culture time, so the 
amount of cells would be expected to decrease drastically by 42 days, if there was no cell 
expansion or proliferation.  
In order to prove this point, the glucose and lactate secretion was measured over the 42 
days period and is shown in Figure 6.33(A) and (B). The glucose is a protein that cells would 
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consume for activity while the lactate would be secreted. If the cells are active, the glucose 
consumption rate and lactate secretion rate increase. On the other hand, the rate of glucose and 
lactate increase would be lower if the cells are in-active. For the glucose and lactate comparison, 
the two metabolic parameters are presented in terms of accumulation with linear regression 
linear applied. The regression lines were analyzed by one-way ANOVA test for statistical 
significance. In the comparison of accumulated glucose, the no-scaffold condition indicates that 
more glucose was consumed and more lactate secreted in the culturing than was consumed in the 
cultures containing HA and Infiltrated HA.  In addition the glucose consumption and lactate 
secretion for the scaffold conditions appears to plateau between 20 and 30 days but not for the 
no-scaffold condition.  But the difference between the rates of accumulation between the three 
conditions was not significant based on the ANOVA test. Also, it is obvious that the glucose 
consumptions of the HA and infiltrated HA conditions are similar while the amount of DNA in 
HA condition is smaller than the amount in infiltrated HA condition. The difference between the 
two results suggested that the cells in infiltrated HA were less active than HA condition but 
infiltrated HA scaffold could still maintain more HUVECs. 
 88 
d5 d1
5
d4
2
0
10000
20000
30000
40000
50000
Control
HA
Infiltrated HA
***
***
N
um
be
r 
of
 c
el
l
 
Figure 6.32 DNA amounts of samples in 42 days 
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Figure 6.33 Cumulated secretions and Ca2+ concentration in culture medium (A) accumulated glucose 
consumption (B) accumulated lactate consumption (C) accumulated Ca2+ concentration 
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Figure 6.33(C) shows that there was little difference between the calcium content of the 
culture over 42 days for the no scaffold condition and the condition with the HA scaffold.  
However, the calcium release from the 2M infiltrated sample increased continuously over the 42 
days.  This latter scaffold condition released more calcium than the pellets studied earlier 
because of the higher surface area.  The Ca release occurred over a long period of time because 
of the fragmentation mechanism that continuously exposes new CaO, leading to the conversion 
to CaCO3 and more release of Ca into solution and deepens the already existing defects.  The 
gradient of decreasing CaO into the interior of the infiltrated samples would result in the 
observed decrease in Ca releasing rate at longer times due to fewer fragmentation events. Note 
that at all time points the calcium concentration in the media was below levels considered toxic 
to cells. The calcium concentration limit is 3mM for general extracellular concentration160 while 
it could up to 40mmol/L in bone marrow18. 
6.2.2 Real Time Polymerase Chain Reaction (RT-PCR) 
In order to exam the gene expression and give insight into the cell development in the culture, 
real-time PCR was applied to the samples. The statistics from the estimates of gene expression 
are divided by the number of cells and are normalized to the gene level of each marker in day 0. 
In this experiment, six genes were examined: vWF, CD144, CD31, CD34, KI-67 and Ang-1. 
Among those, vWF, CD144, CD31, CD34 represent different stages in the lineage of endothelial 
cells derived from HUVECs. The KI-67 is the marker for any cells in a proliferative stage, and 
Ang-1 is the marker for cell-matrix attachment protein expression, which will activate Tie-2 
receptor on the HSCs and promote tight adhesion of HSCs to their niches if HSCs can develop 
from the HUVECs since both show hemangioblast character suggesting they are both related by 
 91 
an early progenitor. As the PCR result is an average level of the gene marker expression inside 
the cells, the same level of a gene marker expression might indicates a gene was expressing 
inside a large amount of cells at a lower level or by a small number of cells at a higher level.  So 
while PCR can be used to examine the development of HUVEC into other types of cells during 
culture it cannot be directly related to cell number. The results are shown in Figure 6.34. 
For CD 144 and CD 31, the two immature endothelial cell markers, the gene expression 
increased between day 0 and day 5. , the no-scaffold condition expressed the highest levels of 
both gene markers at day 5. But these differences were not significant. There is also no 
significant difference between the HA foam condition and the Infiltrated HA foam condition for 
these two gene markers. Also, the expression levels of the two gene markers are almost the same 
for the Day5 and Day 42 samples. 
For CD34, a marker shared by immature endothelial cells and HSCs, the level of 
expression increased a great deal between day 5 and day 42. For the Day 5 samples, the no 
scaffold condition expressed more than infiltrated HA foam condition while the infiltrated HA 
foam culture expressed higher amounts of CD34 than the HA foam condition. Between the 
groups, the differences were significant. After 42 days, the no-scaffold condition still expressed 
the most but the HA foam condition now expressed higher amounts than infiltrated HA foam 
condition. Again the differences between the groups were significant.  
vWF is a gene marker for mature endothelial cells.  Expression of vWF increased over 
the 42 days of culturing.  At Day 5, the no-scaffold condition expressed significantly more vWF 
marker than HA foam condition and infiltrated HA foam condition). After 42 days, HUVECs 
cultured with the scaffolds expressed more vWF than the no scaffold condition. The expression 
of vWF was 2-3 times more than at the day 5 time points. This shows that the surface of the HA 
scaffold is the best condition examined to expand HUVECS into mature endothelial cells and serves 
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as an incentive to study the use of HA scaffolds to promote the formation of vascular-like channels 
using HUVECs. As discussed in section 2.3.5, Ca ion channels play an important role in endothelial 
cell growth and subsequent vascularization161. The resorption/dissolution and the release of Ca ions 
from the scaffold material might create a microenvironment near the surface of the HA that is rich in 
these ions. Such calcium ions might contribute to the maintenance of endothelial cells and also the 
formation of vascular tissue by passing through channels on the surface of these cells to trigger these 
events. 
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Figure 6.34 Gene expression data for HUVECs normalized to day 0 cells (***p<0.001,**p < 0.01,*p < 
0.05) 
According to the RT-PCR results, there is no significant difference between the three 
conditions for KI-67 and Ang-1 marker. Also, the KI-67 and Ang-1 marker expression levels are 
quite low, which indicates that angiogenesis was not active in the HUVEC culture. 
 93 
6.2.3 Fluorescence Activated Cell Sorting (FACs) 
In order to isolate the fraction of the cell population that had certain cell character during culture, 
Fluorescence Activated Cell sorting (FACs) was used.  Since PCR showed an increase in CD34 
expression and the fact that this marker is expressed by endothelial progenitors and HSCs, it was 
decided to use cell marker CD45, which is used to detect mature hematopoietic cells to see if the 
culture could guide HUVECs to differentiate down the hematopoietic cell line.  In FACs, the 
percentages of HUVECs were analyzed at 2 time points, Day 15 and Day 42. The markers used 
in FACs included: CD 235a+ for erythrocytes, CD45+ for mature hematopoietic cells, Lin+ for 
mature hematopoietic lineage cells, including lymphocytes, T-cells, B-cells, granulocytes, and 
macrophages; CD34-/CD31+ for endothelial progenitors, and Lin-, CD34+, CD38- for 
hematopoietic stem cells. 
The CD34 and CD31 makers’ combination could present several type of cell, including 
CD31-CD34+ for hematopoietic progenitor cells, CD31+ CD34+ for endothelial progenitor cells, 
and CD31+CD34- for more mature endothelial cells. 
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Figure 6.35 (A) more mature endothelial cell percentages, (B) hematopoietic progenitor cell percentages, 
and (C) endothelial progenitor cell percentages for three conditions at Day 15 and Day 42 (***p<0.001,**p < 
0.01,*p < 0.05) 
For the more mature endothelial cells in the HUVEC population, figure 6.35(A) shows 
that at day 15 most of the HUVC cells are indeed more mature endothelial cells and there are 
significant differences between the conditions at Day 15 and Day42. At day 15, the fraction of 
CD31+CD34- cells  for the no-scaffold condition is significantly higher than for the infiltrated 
HA condition and the HA condition. For the long-term culture, day 42 shows that the fraction of 
CD31+CD34- cells decrease between day 5 and day 42 for all scaffold conditions and they are 
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now less than 50% of the cells present. .The fraction in the no-scaffold condition was still 
significantly higher than the fraction of CD31+CD34- cells in the infiltrated HA condition. Figure 
6.35 (B) shows the very small fractions of hematopoietic progenitors (CD31-CD34+) in the 
samples, these fractions increased for all the scaffold conditions from day 15 to day 42 and the 
infiltrated HA condition gained a significant higher fraction of these cells than the no-scaffold 
condition at day 42 while no significance appeared at day 15. From Figure 6.35 (C) endothelial 
cell progenitor (CD31+ CD34+) percentages were also quite small but not as small as for the 
(CD31-CD34+) cells. Again the fraction of these cells increased between 15 days and 42 days.  
The no-scaffold condition is significantly higher than the HA condition and the infiltrated HA 
condition after 42 days culture. In Figure 6.35 (B) and (C), significant differences are obtained at 
day 42, while there are significances for mature endothelial cells at both time points.  
Figure 6.36 (A) shows that the percentages of HSCs (Lin-CD34+CD38- ) cells were 
between 0.5% and 2% after 15 days but increased to between 2% to 5% after 42 days suggesting 
that the fraction of HSCs derived from HUVEC cells were increasing in long term culture.  The 
scaffold conditions gave higher percentages than the no-scaffold condition after 15 days and the 
percentage for the infiltrated HA is significantly higher than the no-scaffold condition at this 
time point.  After 42 days (Figure 6.36B) the fraction of Lin-CD34+CD38- increased in all three 
conditions although the trends seen at 15 days were now reversed with the no-scaffold condition 
showing the highest fraction. 
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Figure 6.36 Hematopoietic stem cell percentages for three conditions at (A) Day 15, and (B) Day 42 
Significant differences were showed (*p < 0.05) 
For the hematopoietic cell markers, Figure 6.37 (A) showed that the cell percentages 
expressing CD235a and Lin tended to increase from the no-scaffold to the HA scaffold condition 
and were the highest for the infiltrated scaffold condition after 15 days.  Also the fraction of 
CD235+ cells increased noticeably for all scaffold conditions between day 15 and day 42.  There 
was significantly more Lin+ for the infiltrated HA scaffold compared to the control condition at 
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day 15. These trends continued to develop and by 42 days and the expression for the infiltrated 
HA scaffold condition was significantly higher than the no-scaffold condition for all 
hematopoietic markers including: Lin+, CD45+ and CD235a+ (Figure 6.37B). Also, at Day 42, 
the expression for the infiltrated HA scaffold condition was significantly higher than the HA 
scaffold condition for the CD45+, the mature hematopoietic cell marker. 
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Figure 6.37. CD45, CD235a and Lin positive cell percentages for three conditions at (A) Day 15 and (B) 
Day 42. Significant differences were showed (**p < 0.01,*p < 0.05) 
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In this research, HUVECs, which are commonly used as an endothelial cell lineage 
model, seem to regain HSC functionality during long term culture, particularly in the presence of 
the scaffolds. The presence of mature hematopoietic cells, such as CD235a+ (erythrocytes) and 
CD 45+ (lymphocytes), confirms that endothelial cells can be stimulated into the hematopoietic 
lineage. The infiltrated HA scaffold which released more calcium into the culture, induced more 
of the HUVECs to differentiate into lymphocyte lineage At Day 15, the CD45 fraction for the 
infiltrated HA scaffold condition is significantly higher than that of the HA scaffold condition. 
After 42 days, the CD 45 fraction for the infiltrated HA scaffold condition is significantly higher 
than for the control and the HA scaffold condition.  Therefore, Ca2+ ion concentration may play 
an important role in the differentiation of cells with hemangioblast character (HSCs and 
HUVECS) down the hematopoietic lineage and more study is needed here. 
6.2.4 Colony Unit Forming Assay 
In order to investigate the efficacy of hematopoietic progenitors to differentiate down the 
hematopoietic cell line, the Colony Forming Unit Assay was performed. The HUVECs without 
culturing were assayed as Day 0 as a negative control. Then the HUVECs cultured for 15 or 42 
days under the three scaffold conditions were subject to the CFU assay and the results and 
compare to the Day 0 result (as Table 7). Statistical analysis showed no significant between all 
conditions at Day 15 and Day 42. However, the presence of CFU-E and CFU-GM in the assay 
proved the existence of functional hematopoietic progenitors in the HA and Infiltrated HA 
scaffold conditions after 15 days and 42 days of culture. In both Day 15 and Day 42, there was 
no colony formed in the control conditions, which indicates that the cells cultured in the control 
condition are not able to differentiate down the hematopoietic cell lineage. 
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Table 7 CFU accounting for HUVECs 
Sample CFU-E BFU-E CFU-GM CFU-GEMM 
Day0 0 0 0 0 
Day 15 Control 0 0 0 0 
Day 15 HA 0.67  0 0.67  0 
Day 15 Infiltrated HA 0.67  0 0.67  0 
Day 42 Control 0 0 0 0 
Day 42 HA 0.67  0 1  0 
Day 42 Infiltrated HA 0.67  0 0.33  0 
 
With the CFU testing, the results showed that the HSCs derived from the HUVEC 
population were able to differentiate into erythrocytes and form macrophages.in the presence of 
the scaffolds but not in the control condition in which they appear to retain their stem cell 
character.  The ability of HUVEC to acquire HSC lineage is perhaps not surprising given their 
shared hemangioblast character. Importantly, the CFU results indicates that HUVECs will not 
differentiate into hematopoietic lineages spontaneously in the negative control, but have the 
capacity to differentiate into hematopoietic progenitors and hematopoietic lineage cells in the 
presence of the scaffolds. With HA scaffolds and infiltrated HA scaffolds, the HUVECs appear 
to have attached, proliferated and differentiated, with higher percentages of hematopoietic 
lineages cells produced, such as erythrocytes, lymphocytes, macrophages. 
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6.3 HEMATOPOIETIC STEM CELLS AND OSTEOBLASTS CO-CULTURING 
The second cell model for this study was the hematopoietic stem cells (HSCs) / osteoblasts co-
culture system. The osteoblasts are from the Saos-2 cell line and the HSCs are primary human 
bone-marrow derived stem cells. Three biological repeats, each having HSCs from a different 
donor, were applied to test the biocompatibility of the biphasic material developed in this study.. 
As the cell sources for HSCTs, HSCs are used widely and are difficult in to maintain and 
proliferate during long term in-vitro culture162. There are two types of in-vitro culture model for 
bone marrow derived HSCs, each based on a microenvironment (niche) in which the HSCs are 
found in bone marrow.,  The first is the endosteal niche, close to the bone surface, and the second 
is the vascular niche close to blood vessels.  In the endosteal niche, in which HSCs can self-
renew and differentiate into mature hematopoietic cells, the HSCs are immobilized in association 
with osteoblasts that are attached to the bone surface.  Hence, the osteoblast and HSCs co-culture 
cell model is widely accepted for the HSCs maintenance in this microenvironment, which is 
most pertinent to this study. According to Calvi et al163 there is a parallel relation between the 
osteoblast population increase and the HSCs cell number increase.  Therefore it is expected that 
this co-culture would be most appropriate for expanding the HSC population and controlling 
their fate in in-vitro culture. 
6.3.1 Cell Population and Culturing Observations 
In the three biological repeats of this study, the HSC/Saos-2 co-culture, the total cell number for 
each scaffold condition was counted by microscopy at each harvest time point. Four different 
conditions were used in this experiment, including: (i) the HSCs/Saos-2 cultured without any 
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scaffold as a positive control, (ii) the HSCs/Saos-2 cultured with an HA scaffold, (iii) the 
HSCs/Saos-2 cultured with a 1M Ca2+ solution infiltrated HA scaffold, and (iv) the HSCs/Saos-2 
cultured with a 2M Ca2+  solution infiltrated HA scaffold.  
As it is shown in the Figure 6.38, the total cell number increased with time for all 
scaffold conditions. Unfortunately there is no significant difference between the time points for 
any of the scaffold conditions because of the variability between the behaviors of the HSCs from 
the donors.  Such variability is not unusual for primary human HSCs but it does effect the 
interpretation of significance in this case, especially at day 28 and day 42.  The large error bars 
on the cell number are due to the donor individual variation. 
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Figure 6.38 Total cell number in the samples over a 42 day period samples in 42 days 
In order to further examine the differences for the total cell population between the 
scaffold conditions, the glucose and lactate secretion was measured in media samples extracted 
from the culture every three days over the 42 days period and is shown in Figure 6.36.  As 
described above in the HUVECs culture experiments, the glucose consumption and the lactate 
secretion could reflect the cell activity level. 
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Figure 6.39 (A) accumulated glucose consumption (B) accumulated lactate secretion, and (C) Ca2+ 
concentration over a 42 day period 
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In the comparison of glucose and lactate, there is no significant difference between the 
scaffold conditions at any particular time point. The consumption of glucose and the secretion of 
lactate increased with time in much the same way for all the co-culture wells during 42 days. 
Thus, the four scaffold conditions appear to have similar effects on biocompatibility for the 
HSCs/ Saos-2 co-culture. 
Between the infiltrated scaffolds and pure HS scaffolds, there is a significant difference 
in the Ca2+ concentration measured in samples of the medium extracted every three days over the 
42 day period. With the Ca-rich phase, the infiltrated scaffolds provided a higher Ca 
concentration over the first 3 days as shown in Figure6.39 (C). This enrichment was greater for 
the scaffold infiltrated with the higher calcium nitrate concentration.  Since this should result in 
more soluble second phase it is not surprising that the calcium concentration in the media should 
be higher.  In the HA scaffolds condition, the Ca concentration is significantly lower than the 
infiltrated scaffolds but significantly higher than the medium of the no-scaffold control condition 
at 1day.  Again, this is consistent with the fact that the HA scaffold does not contain the soluble 
second phase but does degrade a little in the culture medium. From day 5 to day 14, the Ca2+ 
concentration of the extracted media samples for the infiltrated scaffolds decreased sharply and 
had a significantly lower Ca2+ concentration than the HA condition and the no-scaffold control 
condition. This was indeed surprising but this could be an active cell differentiation period 
(osteoblast or erythrocytes), for the infiltrated scaffolds conditions and the new cells thus 
produced could then consume the calcium in the media164.  This will be examined later in the 
presentation of the FACS results, such as ALP and CD235a markers. 
From day 16 to the day 42, the Ca2+ concentrations in the four conditions became similar, 
with no significant differences between each other. Interestingly the Ca concentration peaked 
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once again for all the scaffold conditions at around 20 days and then decreased to a minimum 
between 25 and 30 days and then finally rose once more to a peak at 40 days.  There is clear 
cyclic behavior in the Ca2+ concentration of the media for all the scaffold conditions which could 
be associated with the cell activity. Note that the Ca2+ concentration from the medium of the 
osteoblast/HSC co-culture has a quite different trend with time when compared with the HUVEC 
culture.  We hypothesized that difference between the two experiments is caused by the activity 
of the different cell types. According to the researches who have previously studied 
osteoblasts 165, these cells prefer higher Ca2+ concentration and consume Ca2+ ions medium 
during culture. In addition, the Ca2+ dependence of Ca2+-ATPase in erythrocyte membranes 
polyphosphoinositide metabolism has been reported by Buckley166, suggesting that erythrocytes 
will also consume calcium The general osteoblast culture medium, McCoy’s 5A medium, has a 
0.9mM calcium concentration while HSC culture medium has a calcium concentration of only 
0.7mM. Therefore high Ca2+ concentration in the scaffold condition is expected to correlate most 
with higher osteoblasts and erythrocytes activity in culture.  
6.3.2 Fluorescence Activated Cell Sorting  
In order to tracking the cell fate and the differentiation of the cells in the co-culture, 
fluorescence activated cell sorting (FACs) was applied to the three repeats for each scaffold 
condition for the day 5, day 14, day 28 and day 42 time points. In the FACs examination, six 
antibodies were applied, including FITC-Linage cocktail (Lin), PerCPCy-CD34, BV421-CD31, 
PE-CD38, AF647-ALP, and AF700-CD235a. Linage cocktail (Lin) represents for a collection of 
lymphocytes, such as T-cells, B-cells, and macrophages. As a progenitor marker, CD34 was used 
in combination with CD38 to evaluate CD34+/CD38- for HSC stem cells.. CD235a is the marker 
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for erythrocytes, and ALP is used to detect osteoblasts. The CD31 is a marker used for 
endothelial progenitor cells. 
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Figure 6.40 FACs results for HSC/Saos-2 for (A) CD235a, (B) Linage, (C) ALP, and (D) HSCs cell for all 
the conditions during 42 days of culture 
In Figure6.40 (A), comparing with day 0 fresh cells, the erythrocytes percentages 
decreased in the control no-scaffold condition by 5 days and although the percentage of these 
cells in the control increased at longer times it never regained the percentage in day 0.  However, 
for the other three scaffold conditions, the erythrocytes percentages increased.  Erythrocytes can 
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live for a maximum of 2 weeks and usually die well before that.  In addition they are not capable 
of differentiation themselves and must be derived from HSCs present in this culture.  The results 
indicated that erythrocytes are present throughout long term culture and the fraction increases for 
the scaffold conditions.  This suggests that HSCs are differentiating into erythrocytes throughout 
the culture period and that the scaffolds seem to promote this.  
There is a different trend for the Lin positive cells, which are lymphocytes derived for 
HSCs. There is no significantly change in the cell percentage until 42 days.  At 42days Figure 
6.40 (B), shows the cell percentage expression Lin was sharply higher for the scaffold 
conditions. The control condition with no scaffold still had a low and stable percentage of Lin 
positive cell percentage. The large variability between the biological repeats with different 
donors contributed to the large error bars and no significant differences. 
Since the medium was chosen for HSC culturing rather than the culturing of osteoblasts, 
it is no surprise that the cell percentage for ALP (Figure 6.40(C)), osteoblast cell marker, 
decreased in the control condition as the culture time increased. At day 42, there is a significant 
difference between the percentages of cells expressing ALP in the control condition and the 2M 
Ca2+ solution infiltrated HA scaffolds condition.  In the scaffolds conditions, the ALP marker 
percentages increased with culture time for the HA scaffold condition, 1M Ca2+ infiltrated HA 
condition and the 2M Ca2+ infiltrated condition. 
Figure6.40 (D) shows there is large decrease in the fraction of HSCs within the first 5 
days and then there is no significant difference between the scaffold conditions at each time 
point. However, the results at day 42 for all the scaffold conditions indicated that the HSCs were 
then maintained in long term culture over 42 days. 
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In the FACs results, the large error bars appeared due to the biological variation between 
different HSC donors. In order to reduce the individual difference, the normalization is applied to 
the FACs result.  At each time point, the FACs results for the four scaffold conditions were 
normalized to the control in each repeat. The normalized FACs results are shown in Figure 6.41 
(A) to (D). 
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Figure 6.41 Normalized FACs results for HSC/Saos-2 for (A) CD235a, (B) Linage, (C) ALP, and (D) 
HSCs cell for all the conditions during culture 
After normalizing, the variation between the donors is reduced and there are significant 
differences between the scaffold conditions. For the CD235a erythrocyte marker, the cell 
percentages for the HA scaffold condition and the 1M infiltrated HA scaffold condition are 
significantly higher than the no-scaffold control on day 5. 2M infiltrated HA scaffold condition 
and 1M HA scaffold infiltrated condition are also significantly higher than the control condition 
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on Day14.  The erythrocytes expression enhancement on the scaffolds conditions maintained at 
the longer time points but is no longer significant.  These results suggest that HSCs are more 
likely to differentiate into erythrocytes on the scaffolds, perhaps due to the release of calcium. 
The normalization reveals differences between the scaffold conditions for the Lin marker 
at the longer time points. Both of the HA condition and the 2M infiltrated HA condition 
expressed for significantly higher cell percentages of Lin marker than the control at day 42. The 
significances between the control and the scaffolds conditions demonstrated once again that the 
scaffolds introduced into the HSC/Saos-2 co-cultures could facilitate HSC differentiation. 
For ALP, the osteoblast cell type marker, there are greater significance to the 
enhancement at longer sintering times compared to the control. Significantly more osteoblasts 
were maintained in the two infiltrated scaffolds conditions compared to the control condition 
(p<0.05) at day 28. After another 2 weeks, the differences became more significant with 
p<0.001. Meanwhile, there is no significant difference at each time point between the HA 
condition and the other scaffold conditions, as well as between the 1M infiltrated HA scaffolds 
condition and the 2M infiltrated HA condition during 42 days.  It is clear that the scaffolds allow 
the osteoblast population to be maintained and even increase whereas the control results in a 
decrease in osteoblasts through the culture period.  This could be due to osteoblast attachment to 
the scaffolds and the calcium content of the media. 
Figure 6.41 (D) shows the HSC cell percentages are defined by the marker combination 
of Lin negative, CD34 positive and CD38 negative. This removed more mature hematopoietic 
progenitors and also endothelial progenitors that may express CD34.  The infiltrated HA 
scaffolds conditions had significantly higher HSC cell percentages than the control condition at 
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day 42 with p<0.05. Also, in the culture of the 2M infiltrated HA condition, HSC percentages are 
significantly larger than that in the control condition at day 14. 
In summary, the FACs results show that there are significant increments in cell 
percentages for the infiltrated HA conditions over the control condition for erythrocytes, 
osteoblasts, and HSCs.  For the hematopoietic lineage cell percentages, there is a significant 
difference between the HA condition and the control condition at long time points. 
6.3.3 Colony Forming Unit Assay  
In HSCs in-vitro culture experiments, Colony Forming Unit Assay (CFU) is an important and 
necessary method to investigate the ability of hematopoietic progenitor cells and HSCs to 
differentiate after being cultured. In the CFU testing, 5000 cells were extracted for cultures of 
each  scaffold condition at each harvest time point, mixed with CFU assay, and cultured for 
another 15 days. After 15days, the wells were observed under a microscope to identify the types 
of colonies formed by differentiation of HSCs and count the colony numbers. Four different 
types of colonies were identified in this study and their frequencies compared to expected 
numbers as given by the manufacturer: These included: CFU-E (Colony Forming Unit – 
Erythrocyte), BFU-E (Burst Forming Unit – Erythrocyte), CFU-GM (Colony Forming Unit – 
Granulocytes, Macrophage) and CFU-GEMM (Colony Forming Unit – Granulocyte, 
Erythrocyte, Macrophage, and Megakaryocyte)158. The results are shown in Figure 6.42. 
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Figure 6.42 CFU colonies accounting of HSC/Saos-2 in (A) CFU-E and (B) CFU-GM for all the 
conditions at harvest time points 
There were no BFU-E and CFU-GEMM observed for any of the cultured HSCs. CFU-E 
are erythrocytes colonies, which indicates the HSC progenitors in the culture that have the 
potential to proliferate and differentiate into erythrocytes. Figure 6.42 (A), shows that after the 
longer culturing times, there are significant differences between the infiltrated HA scaffolds and 
the control condition. At day 28, the 2M infiltrated HA condition had significantly more CFU-E 
colonies than the control condition. Both 1M and 2M infiltrated HA scaffolds conditions gave 
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significantly higher numbers of CFU-E colonies than the control condition at day 42. The Figure 
6.42 (A) provides strong evidence that the infiltrated scaffolds could increase the fraction of 
HSCs which have the potential to differentiate into blood cells. 
For the CFU-GM result, Figure 6.42 (B), there was no significant difference between the 
conditions at each time point. However, when we group the CFU-GM colony counts for each 
donor, the infiltrated scaffold conditions have higher CFU-GM colony numbers than the control 
condition harvested at 42 days. 
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Figure 6.43 CFU-GM colonies accounting of HSC/Saos-2 of each repeat 
In the Figure 6.42, the results for the different scaffold conditions are grouped by donor 
at each time point.  It then becomes clear that the infiltrated HA scaffold conditions enhanced the 
number of the hematopoietic lineage cell colonies compared to the control. This trend suggests 
that HSCs cultured in the presence of the scaffolds have a higher probability of differentiating 
into the hematopoietic cell linage. 
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7.0  CONCLUSIONS 
7.1 EFFECT OF THE INFILTRATION PROCESS ON HA AND CONSEQUENT 
EFFECT ON DISSOLUTION 
1. A biphasic calcium phosphate ceramic can be created by infiltrating calcium salts into 
HA scaffolds that has been partially sintered. The infiltration process and consequent heat 
treatment produce HA with minor amounts of CaO. Exposure to moisture causes the 
transformation of CaO to CaCO3, another highly soluble Ca-rich phase,  
2. The biphasic calcium phosphate ceramic has a higher degradation rate in static tri-
buffered saline over at least 28 days. The calcium ion release from the Ca infiltrated HA is 
consistently higher than that of HA for dense pellets and higly porous foams over 28 days. 
Therefore this part of the hypothesis was correct. 
3. The transformation of CaO to CaCO3 on exposure to moisture also caused 
fragmentation of the ceramic by removing adjacent HA grains leading to relatively large surface 
defects that grew deeper with exposure time. 
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7.2 PREPARATIONS OF A BIPHASIC CALCIUM PHOSPHATE SCAFFOLD AND 
THE CULTURING OF HUVECS 
Human umbilical vein endothelial cells (HUVECs) were successfully cultured on HA and 
infiltrated HA scaffolds over 42 days. When compared to a control with no scaffold, it was found 
that the presence of HA or Infiltrated HA scaffold increased the expression of HSCs, with a 
combination marker of CD34+ /CD38-/Lin-, and acquired the expression of CD45 and Lin, two 
mature hematopoietic cell marker, mainly for lymphocytes . This showed for the first time that 
calcium phosphate scaffolds can stimulate HUVEC cells, commonly recognized as endothelial 
progenitors, to acquire HSC character and then differentiate down the hematopoietic lineage.  
Additionally, the CFU assay test showed that the HSCs derived from HUVEC cells can then 
differentiate and form erythrocytes colonies and granulocytes/ macrophages colonies. Finally 
HA scaffold was important to the differentiation to erythrocytes after 42-day culture; whereas the 
high calcium concentration associated with the impregnated scaffolds may be more important for 
HUVECs differentiation into lymphocytes. In summary, a small fraction of HUVEC cells can 
develop HSC character in culture and the scaffolds were found to improve HSC maintenance in 
long term culture and some increase in HSC cell fraction but there was no evidence of a major 
expansion of the HSC population derived from HUVEC cells. 
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7.3 PREPARATIONS OF A BIPHASIC CALCIUM PHOSPHATE SCAFFOLD AND 
THE CULTURING OF HSC/OSTEOBLAST CO-CULTURE 
Hematopoietic stem cells and osteoblasts were successfully co-cultured over 42days in 
the presence of HA and infiltrated HA scaffolds.  The differentiation of the HSC cells was 
indicated by cell marker for mature hematopoietic cells in FACs. In this study, the 
biocompatibility of the infiltrated HA scaffolds was shown to be similar to the HA scaffolds. 
HSCs and osteoblast maintenance during 42 days of co-culture was improved by the presence of 
the scaffolds.. FACs analysis of erythrocytes marker (CD235a) ,hematopoietic cell maker( Lin) 
and the  CFU assay, showed that the infiltrated HA scaffolds resulted in higher fractions of 
hematopoietic cells after long term culture and the HSC s cultured on the infiltrate scaffolds 
showed more potential to differentiate down the hematopoietic lineage compared with the 
control.  Again, there was no major expansion of the HSC population. 
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8.0  SUGGESTED FUTURE WORK 
8.1 BIOREACTOR CONSTRUCTION 
The effect of the scaffold materials on the HSC/osteoblast co-culture should be examined under 
perfusion conditions using bioreactors.  This is known to affect the fate of HSC cells making 
them more susceptible to differentiation.  In particular the ability of the scaffolds to maintain the 
HSC population in long term culture should be investigated for the infiltrated scaffolds. 
8.2 THE BIOCOMPATABILITY OF THE HIGH CALCIUM CERAMICS WITH 
HSCS 
The infiltration method only results in minor fractions of the second phase in HA and as a result 
the dissolution and the fragmentation of the scaffold is slow.  To improve the solubility of the 
scaffolds and their ability to degrade, other methods such as mixed powder techniques should be 
used to make ceramics with much larger fractions of the CaO second phase.  The solubility of 
these ceramics in saline should then be investigated.  If scaffolds can be made to degrade in 
culture it would allow the cells to remodel the space into tissue like structures. 
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8.3 THE DIFFERENTIATION PATHWAY OF HUVECS TOWARDS 
HEMATOPOIETIC LINEAGE 
In the study, the biocompatibility of the material has been tested with HUVECs. The positive 
results of FACs and PCR on the differentiation to hematopoietic cells, demonstrated that the 
infiltrated HA scaffolds could stimulate certain HUVEC cells into hematopoietic cell linages.  If 
this could be achieved at higher cell fractions it may be possible to use HUVECS as a source of 
endothelial cells and hematopoietic cells.  More cell biology experiments must be conducted on 
the of the scaffolds and calcium release on the differentiation pathway and the role of 
hemangioblast character in determining if HUVECS will differentiate to HSCs at higher cell 
fractions. 
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